Oral tolerance: Mechanisms and therapeutic applications

Advances in Immunology

Volumn 73, Issue 73, 1999, Pages 153-264

  Faria, Ana M C ^a   Weiner, Howard L ^a  

^a Brigham and Women's Hospital Center for Neurologic Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CHOLINERGIC RECEPTOR; CYTOKINE; GLATIRAMER; GLUTAMATE DECARBOXYLASE; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; INSULIN;

ANTIGEN PRESENTATION; ARTHRITIS; CELLULAR IMMUNITY; CLONAL ANERGY; DIABETES MELLITUS; DISEASE MODEL; DRUG STRUCTURE; ENZYME ACTIVITY; GENETIC ANALYSIS; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE ABSORPTION; INTESTINE FLORA; INTRANASAL DRUG ADMINISTRATION; KINETICS; NONHUMAN; NOSE MUCOSA; ORAL DRUG ADMINISTRATION; PEYER PATCH; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; TRANSGENIC MOUSE; UVEITIS;

ANIMALS; ANTIGENS; AUTOIMMUNE DISEASES; HUMANS; IMMUNE TOLERANCE; INFLAMMATION; INTESTINAL MUCOSA; MOUTH; NASAL MUCOSA;

EID: 0033066588     PISSN: 00652776     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0065-2776(08)60787-7     Document Type: Article

References (566)

1. Abbas, A. K., Murphy, K. M., and Sher, A. (1996). Functional diversity of helper T lymphocytes. Nature (London) 383, 787-793.
2. Agren, L. C., Ekman, L., Lowenadler, B., and Lycke, N. Y. (1997). Genetically engineered nontoxic vaccine adjuvant that combines B cell targeting with immunomodulation by cholera toxin Al subunit. J. Immunol. 158, 3936-3946.
3. Aichele, P., Kyburz, D., Ohashi, P. S., Odermatt, B., Zinkernagel, R. M., Hengartner, H., and Pircher, H. (1994). Peptide-induced T-cell tolerance to prevent autoimmune diabetes in a transgenic mouse model. Proc. Natl. Acad. Sci. U.S.A. 91, 444-448.
4. Allan, C. H., Mendrick, D. L., and Trier, J. S. (1993). Rat intestinal M cells contain acidic endosomal-lysosomal compartments and express class II major histocompatibility complex determinants. Gastroenterologij 104, 698-708.
5. al-Sabbagh, A., Miller, A., Santos, L. M. B., and Weiner, H. L. (1994). Antigen-driven tissue-specific suppression following oral tolerance: Orally administered myelin basic protein suppresses proteolipid induced experimental autoimmune encephalomyelitis in the SJL mouse. Eur. J. Immunol. 24, 2104-2109.
6. al-Sabbagh, A., Nelson, P. A., Akselband, Y., Sobel, R. A., and Weiner, H. L. (1996a). Antigen-driven peripheral immune tolerance: Suppression of experimental autoimmmune encephalomyelitis and collagen-induced arthritis by aerosol administration of myelin basic protein or type II collagen. Cell. Immunol. 171, 111-119.
7. al-Sabbagh, A. M., Goad, E. P., Weiner H. L., and Nelson, P. A. (1996b). Decreased CNS inflammation and absence of clinical exacerbation of disease after six months oral administration of bovine myelin in diseased SJL/J mice with chronic relapsing experimental autoimmune encephalomyelitis. J. Neurosci. Res. 45, 424-429.
8. al-Sabbagh, A. M., Garcia, G., Slavin, A. J., Weiner, H. L., and Nelson P. A. (1997). Combination therapy with oral myelin basic protein and oral methotrexate enhances suppression of experimental autoimmune encephalomyelitis. Neurology 48, A421.
9. Anderton, S., and Wraith, D. (1998). Hierarchy in the ability of T-cell epitopes to induce peripheral tolerance to antigens from myelin. Eur. J. Immunol. 28, 1251-2161.
10. Andre, C., Heremans, J. F., Vaerman, J. P., and Cambiaso, C. L. (1975). A mechanism for the induction of immunological tolerance by antigen feeding: Antigen-antibody complexes. J. Exp. Med. 142, 1509-1519.
11. Antozzi, C., Baggi, F., Andreetta, F., Simoncini, O., Longhi, R., Cornelio, F., and Mantegazza, R. (1998). Oral administration of an immunodominant TAChR epitope modulates antigen-specific T-cell responses in mice. Ann. N.Y. Acad. Sci. 841, 568-571.
12. Apple, R. J., Domen, P. L., Muckerheide, A., and Michael, J. G. (1988). Cationization of proteins antigens. IV. Increased antigen uptake by antigen-presenting cells. J. Immunol. 140, 3290-3295.
13. Arakawa, T., Yu, J., Chong, D. K., Hough, J., Engen, P. C., and Langridge, W. H. (1998). A plant-based cholera toxin B subunit-insulin fusion protein protects against the development of autoimmune diabetes. Nature Biotechnol. 16, 934-938.
14. Aramaki, Y., Fujii, Y., Suda, IL, Suzuki, I., Yadomae, T., and Tsuchiya, S. (1994). Induction of oral tolerance after feeding of ragweed pollen extract in mice. Immunol. Lett. 40,21-25.
15. Ariano, R., Panzani, R. C., and Augeri, G. (1998). Efficacy and safety of oral immunotherapy in respiratory allergy to Parietariajudaica pollen. A double-blind study. J. Invest. Allcrg. Clin. Immunol. 8, 155-160.
16. Asherson, G. L., Zembala, M., Perera, M. A. C. C., Mayhew, B., and Thomas, W. R. (1977). Production of immunity and unresponsiveness in the mouse by feeding contact sensitizing agents and the role of suppressor cells in the Peyer's patches, mesenteric lymph nodes and other lymphoid tissues. Cell. Immunol. 33, 145-155.
17. Astwood, J. D., Leach, J. N., and Fuchs, R. L. (1996). Stability of food allergens to digestion in vitro. Cell. Immunol. 14, 1269-1273.
18. Avrameas, S. (1991). Natural autoantibodies: From 'horror autotoxicus' to 'gnothi seauton. Immunol. Today 12, 154-159.
19. Bagot, M., Charue, D., Flechet, M. L., Terki, N., Toma, A., and Revuz, J. (1995). Oral desensitization in nickel allergy induces a decrease in nickel-specific T-cells. Eur. J. Dcnnatol. 5, 614-617.
20. Bai, X. F., Shi, F. D., Xiao, B. G., Li, H. L., van der Meide, P. IL, and Link, H. (1997). Nasal administration of myelin basic protein prevents relapsing experimental autoimmune encephalomyelitis in DA rats by activating regulatory cells expressing IL-4 and TGF-β mRNA. J. Neuroimmunol. 80, 65-75.
21. Bai, X. F., Li, H. L., Shi, F. D., Liu, J. Q., Xiao, B. G., Van der Meide, P. H., and Link, H. (1998). Complexities of applying nasal tolerance induction as a therapy for ongoing relapsing experimental autoimmune encephalomyelitis (EAE) in DA rats. Clin. Exp. Immunol. Ill, 205-210.
22. Bandeira, A., Larsson, E. L., Forni, L., Pereira, P., and Coutinho, A. (1987). In vivo activated splenic T-cells are refractory to interleukin 2 growth in vitro. Etir. J. Iminnnol. 17, 901-909.
23. Barnett, M. L., Combitchi, D., and Trentham, D. E. (1996). A pilot trial of oral type II collagen in the treatment of juvenile rheumatoid arthritis. Artliritis PJwum. 39,623-628.
24. Barnett, M. L., Kremer, J. M., St. Clair, E. W., Clegg, D. O., Fürst, D., Weisman, M., Fletcher, M. J. F., Lavin, P. T., Finger, E., Morales, A., Le, C. H., and Trentham, D. E. (1998). Treatment of rheumatoid arthritis with oral type II collagen: Results of a multicenter, double-blind, placebo-controlled trial. Arthritis PJieum. 41, 290-297.
25. Barone, K. S., Tolarova, D. D., Ormsby, I., Doetschman, T., and Michael J. G. (1998). Induction of oral tolerance in TGF-beta 1 null mice. J. Immunol. 161, 154-160.
26. Bartholomeusz, R. C. A., Forrest, B. D., Labroov, J. T., Ey, P. L., Pyle, D., Shearman, D. J. C., and Rowley, D. (1990). The serum polymeric IgA antibody response to typhoid vaccination; its relationship to intestinal IgA response. Immunology 69, 190-194.
27. Battisto, J. R., and Miller, J. (1963). Mesenteric vein administration of picryl chloride produces effects similar to oral feeding. Proc. Soc. Exp. Biol. Med. Ill, 111-115.
28. Becker, K. J., McCarron, R. M., Ruetzler, C., Laban, O., Sternberg, E., Flanders, K. C., and Hallenbeck, J. M. (1997). Immunologie tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia. Proc. Natl. Acad. Sci. U.S.A. 94,1087310878.
29. Bellmann, K., Kolb, H., Hartmann, B., Rothe, H., Rowsell, P., Rastegar, S., Burgliardt, K., and Scott, F. W. (1997). Intervention in autoimmune diabetes by targeting the gut immune system. Int. J. Immunophannacol. 19, 573-577.
30. Bellman, K., Kolb, H., Rastegar, S., Jee, P., and Scott, F. W. (1998). Potential risk of oral insulin with adjuvant for the prevention of Type I diabetes: A protocol effective in NOD mice may exacerbate disease in BB rats. Diabetologia 41, 844-847.
31. Ben-Sasson, S. Z., Le Gros, G., Conrad, E. H., Finkelman, F. D., and Paul, W. E. (1990). IL-4 production by T-cells from naive donors.J. Immunol. 145, 1127-1136.
32. Benson, J. M., Stuckman, S. S., Cox, K. L., Wardrop, R. M., Gienapp, I. E., Cross, A. H., Trotter, J. L., and Whitacre, C. C. (1999). Oral administration of MBP is superior to myelin in suppressing established relapsing experimental autoimmune encephalomyelitis. J. Immunol, in press.
33. + T-cells that suppress adoptive transfer of diabetes. J. Atitoimmnn. 1, 655-663.
34. Bergerot, I., Fabien N., Mayer, A., and Thivolet, C. (1996). Active suppression of diabetes after oral administration of insulin is determined by antigen dosage. Ann. N.Y. Acad. Sci. 778, 362-367.
35. Bergerot, I., FioLx, C., Peterson, J., Moulin, V., Rask, C., Fabien, N., Lindblad, M., Mayer, A., Czerkinsky, C., Holmgren, J., and Thivolet, C. (1997). A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes. Proc. Natl. Acad. Sci. U.S.A. 94, 4610-4614.
36. Bersani Amado, C. A., Barbuto, J. A. M., and Jancar, S. (1991). Comparative study of adjuvant induced arthritis in susceptible and resistant strains of rats. II. Effects of oral administration of BCG and PPD.J. PJwumatol. 17, 738-742.
37. Besredka, A. (1909). De l'anaphylaxie. Sixième mémoire de l'anaphylaxie lactique. Ann. Inst. Pasteur 23, 166-174.
38. Besredka, A. (1919). De la vaccination contre les états typhoïdes par la voie buccale. Ann. Inst. Pasteur 33, 882-903.
39. Besredka, A. (1927). "Local Immunization." Balliere, Tindal-Cox, London.
40. Biancone, L., Paganelli, R., Fais, S., Squarcia, O., D'Offizi, G., and Pallaone, F. (1987). Peripheral and intestinal lymphocyte activation after in vitro exposure to cow's milk antigens in normal subjects and in patients with Crohn's disease. Clin. Immtinol. Immttnopathol. 45, 491-498.
41. Bitar, D. M., and Whitacre, C. C. (1988). Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein. Cell. Immtinol. 112,364-370.
42. Blanas, E., Carbone, F. R., Allison, J., Miller, J. F. A. P., and Heath, W. R. (1996). Induction of autoimmune diabetes by oral administration of autoantigen. Science 274,1707-1709.
43. Bland, P. W., and Kambarage, D. M. (1991). Antigen handling by the epithelium and lamina propria macrophages. Gastroenterol. Clin. North Am. 20, 577-596.
44. Bland, P. W., and Warren, L. G. (19S6). Antigen presentation by epithelial cells of the rat small intestine. II. Selective induction of suppressor T-cells. Immunology 58, 9-14.
45. Blank, M., George, J., Barak, V., Tincani, A., Koike, T., Shoenfeld, Y. (1998). Oral tolerance to low dose B2-Glycoprotein. I: Immunomodulation of experimental antiphospholipid syndrome.J. Immunol. 161,5303-5312.
46. Bloch, K. J., Perry, R., Bloch, M., and Walker, A. W. (1983). Induction of (partial) systemic tolerance in primed rats subjected to prolonged oral administration of antigen. Ann. N.V. Acad. Sci. 409, 787-788.
47. Bloom, B. R., Modlin, R. L., and Salgame, P. (1992). Stigma variations: Observations on suppressor T-cells and leprosy. Annit. Rev. Immtinol. 10, 453-488.
48. Border, W. A., Ward, H. J., Kamil, E. S., and Cohen, A. H. (1982). Induction of membranous nephropathy in rabbits by administration of an exogenous cationic antigen.J. Clin. Invest. 69, 451-458.
49. Brandtzaeg, P. (1998). Development and basic mechanisms of human gut immunity. Nutr. Rev. 56, S5-18.
50. Brod, S. A., al-Sabbagh, A., Sobel, R. A-, Hafler, D. A., and Weiner, H. L. (1991). Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens. IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig. Ann. Netirol. 29, 615-622.
51. Broug-Holub, E., Persoons, J. IL, Schornagel, K., and Kraal, G. (1995). Changes in cytokine and nitric oxide secretion by rat alveolar macrophages after oral administration of bacterial extracts. Clin. Exp. Immtinol. 101, 302-307.
52. Browning, M. J., and Parrott, D. M. (1987). Protection from chronic immune complex nephritis by a single dose of antigen administered by the intragastric route. Adv. Exp. Med. Biol. 216B, 1619-1625.
53. Bruce, M. G., and Ferguson, A. (19S6a). The influence of intestinal processing on the immunogenicity and molecular size of absorbed, circulating ovalbumin in mice. Immunology, 59, 295-300.
54. Bruce, M. G., and Ferguson, A. (1986b). Oral tolerance to ovalbumin in mice: Studies of chemically modified and 'biologically filtered' antigen. Immunology 57, 627-630.
55. Bruce, M. G., and Ferguson, A. (1987). Oral tolerance induced by gut-processed antigen. Adv. Exp. Med. Biol. 216A, 721-731.
56. Burnet, M. (1959). "The Clonal Selection Theory of Acquired Immunity." Vanderbilt Univ. Press, Nashville, Tennessee.
57. Burstein, H. J., and Abbas, A. K. (1993). In vivo role of interleukin 4 in T-ceII tolerance induced by aqueous protein antigen. J. Exp. Med. 177, 457-463.
58. Calne, R. Y., Sells, R. A., and Pena, J. R. (1969). Nature (London) 223, 472-476.
59. Campbell, D. A., Jr., Lorber, M. I., Sweeton, J. C., Turcotte, J. G., Niederhuber, J. E., and Beer, A. E. (1984). Breast feeding and maternal-donor renal allografts. Possibly the original donor-specific transfusion. Transplantation 37, 340-344.
60. Cantor, H. M., and Dumont, A. E. (1967). Hepatic suppression of sensitization to antigen absorbed into the portal system. Nature, (London) 215, 744-745.
61. Cardillo, F., Nomizo, A., and Mengel, J. (1998). The role of the thymus in modulating γδ T-cell suppressor activity during experimental Trypanosoma crtizi infection. Int. Immunol. 10, 107-116.
62. Carvalho, C. R., Verdolin, B. A., de Souza, A. V., and Vaz, N. M. (1994). Indirect effects of oral tolerance in mice. Scand. J. Immunol. 39, 533-538.
63. Carvalho, C. R., Verdolin, B. A., and Vaz, N. M. (1997). Indirect effects of oral tolerance cannot be ascribed to bystander suppression. Scand. J. Immunol. 45, 276-281.
64. + T-cell tolerance that is reversible and requires CD-CDS cells and IFN-yJ. Exp. Med. 186, 71-81.
65. Cerf-Bensussan, N., Quaroni, A., Kumick, J., and Bhan, A. (1984). Intraepithelial lymphocytes modulate la expression by intestinal epithelial cells. J. Immunol. 132, 2244-2251.
66. Challacombe, S. J., and Tomasi, T. B. (1980). Systemic tolerance and secretory immunity after oral immunization. J. Exp. Med. 152, 1459-1472.
67. Challacombe, S. J., Rahman, D., Jeffrey, H., Davis, S. S., and O'Hagan, D. T. (1992). Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen. Immunology 76, 164-168.
68. Chase, M. (1946). Inhibition of experimental drug allergy by prior feeding of the sensitizing agent. Proc. Soc. Exp. Biol. Med. 61, 257-259.
69. Chen, Y., Kuchroo, V. K., Inobe, J.-I., Hafler, D. A., and Weiner, H. L. (1994). Regulatory T-cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis. Science 265, 1237-1240.
70. Chen, Y., Inobe, J., Marks, R., Gonnella, P., Kuchroo, V. K., and Weiner, H. L. (1995a). Peripheral deletion of antigen-reactive T-cells in oral tolerance. Nature (London) 376, 177-180.
71. Chen, Y., Inobe, J., and Weiner, H. L. (1995b). Induction of oral tolerance to myelin basic protein in Cue-depleted mice: Both CD4'1' and CD8+ cells mediate active suppression. J. Immunol. 155, 910-916.
72. Chen, Y., Inobe, J., Kuchroo, V. K., Baron, J. L., Janeway, C. A., Jr., and Weiner, H. L. (1996). Oral tolerance in myelin basic protein T-cell receptor transgenic mice: Suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. Proc. Natl. Acad. Sci. U.S.A. 93, 388-391.
73. Chen, Y., Inobe, J.-I., and Weiner, II. L. (1997). Inductive events in oral tolerance in the TCR transgenic adoptive transfer model. Cell. Immunol. 178, 62-68.
74. Chen, L. Z., Hochwald, G. M., Huang, C., Dakin, G., Tao, H., Cheng, C., Simmons, W. J., Dranoff, G., and Thorbecke, G. J. (1998a). Gene therapy in allergie encephalomyelitis using myelin basic protein-specific T-cells engineered to express latent TGF-β1. Proc. Natl. Acad. Sci. U.S.A. 95, 12516-12521.
75. Chen, W., Jin, W., Cook, M., Weiner, W. L., and Wahl, S. M. (1998b). Oral delivery of group A streptococcal cells walls augments circulating TGF-β and suppresses streptococcal cell wall arthritis.J. Immunol. 161, 6297-6304.
76. + T cells. J. Exp. Med. 188, 1849-1857.
77. Chesnut, R. W., and Grey, H. M. (1981). Studies on the capacity of B cells to serve as antigen presenting cells. J. Immunol. 126, 1075-1079.
78. Chesnut, R. W., Colon, S. M., and Grey, H. M. (1982). Antigen presentation by normal B cells, B cell tumors, and macrophages: Functional and biochemical comparison.J. Immunol. 128, 1764-1768.
79. Chu, C. Q., and Londei, M. (1999). Differential activities of immunogenic collagen type 11 peptides in thé induction of nasal tolerance to collagen-induced arthritis.J. Autoimmun. 12(1), 35-42.
80. Chung, S. and Gorczynski, R. (1995). Induction of T-cell h)poresponsiveness by intraliepatic modulation of donor antigen-presenting cells. Immunology 85, 582-590.
81. Ciaessen, A. M., von Blomberg, B. M., De Groot, J., Wolvers, D. A., Kraal, G., and Scheper, R. J. (1996). Reversal of mucosal tolerance by subcutaneous administration of interleukin12 at the site of attempted sensitization. Immunology 88, 363-367.
82. Clark, S. L. (1979). The ingestion of proteins and colloidal materials by columnar absorptive cells in the small intestine in suckling rats and mice.J. Biophys. Biochem. Cytol. 5,41-49.
83. Cohen, I., and Young, D.D. (1991). Autoimmunity, microbial immunity and the immunological homunculus. Immunol. Today 12, 105-110.
84. Conde, A. A., Stransky, B., Faria, A. M., and Vaz, N. M. (1998). Interruption of recently induced immune responses by oral administration of antigen. Braz. J. Mcd. Biol. Res. 31, 377-380.
85. Cook, P. M., and Oison, G. F. (1979). Ingested mineral fibers: Elimination in human urine. Science 204, 195-199.
86. Courtenay, J. S., Dallman, M. S., Dayan, A. D., Martin, A., and Mosedale, B. (1980). Immunization against heterologous type II collagen induces arthritis in mice. Nature (London) 283, 666-668.
87. Coûtant, R., Zeidler, A., Rappaport, R., Schatz, D., Schwartz, S., Raskin, P., Rogers, D., Bode, B., Crockett, S., Marks, J., Deeb, L., Chalew, S., and MacLaren, N. (1998). Oral insulin therapy in newly-diagnosed immune mediated (type I) diabetes. Preliminary analysis of a randomized double blind placebo controlled study. Diabetes 47 (Suppl. 1), A97.
88. Cowdery, J. S., and Johlin, B. J. (1984). Regulation of the primary in vitro response to TNP-polymerized ovalbumin by T suppressor cells induced by ovalbumin feeding. J. Immunol. 132, 2783-2789.
89. Craig, S. W., and Cebra, J. J. (1971). Peyer's patches: An enriched source of precursors for IgA-producing immunocytes in the rabbit. J. Exp. Med. 134, 188-200.
90. Crispe, N., and Mehal, W. (1996). Strange brew: T-cells in the liver. Immunol. Today 17, 522-525.
91. Cross, A. H., Tuohy, V. K., and Raine, C. S. (1993). Development of reactivity to new myelin antigens during chronic relapsing autoimmune demyelination. Cell. Immunol. 146, 261-270.
92. Czerkinsky, C., and Holmgren, J. (1995). The mucosal immune system and prospects for anti-infectious and anti-inflammatory vaccinés. Immunologist 3, 97-193.
93. Czerkinsky, C., Prince, S. J., Michalek, S. M., Jackson, S., Russell, M. W., Moldoveanu, Z., McGhee, J. R., and Mestecky, J. (1987). IgA antibody-producing cells in peripheral blood after antigen ingestion: Evidence for a common mucosal immune system in humans. Proc. Natl. Acad. Sci. U.S.A. 84, 2449-2453.
94. Czerkinsky, C., Sun, J. B., Lebens, M., Li, B. L., Rask, C., Lindblad, M., and Holmgren, J. (1996). Cholera toxin B subunit as transmucosal carrier-delivery and immunomodulating system for induction of antiinfectious and antipathological immunity. Ann. N.f. Acad. Sci. 13, 185-193.
95. Czerkinsky, C., Sun, J., and Holmgren, J. (1999). Oral tolerance and anti-pathological vaccines. Curr. Top. Microbiol. Immunol. 236, 79-91.
96. Dahl, G. M., Telemo, E., Westrom, B. R., Jakobsson, I., Lindberg, T., and Karlsson, B. W. (1984). The passage of orally-fed proteins from mother to foetus in the rat. Com/). Biochem. Phtjsiol. A. 77, 199-201.
97. Dahlman, A., Ahlstedt, S., Hanson, L. A., Telemo, E., Wold, A. E., and Dalilgren, U. I. (1992). Induction oflgE antibodies and T-cell reactivity to ovalbumin in rats colonized with EscJiericJiia coli genetically manipulated to produce ovalbumin. Immunology 76,225-228.
98. Dahlman, A., Telemo, E., Ahlstedt, S., Hanson, L. A., Wold, A. E., and Dahlgren, U. I. ( 1994). Immune response against ovalbumin in rats colonized with an ovalbumin-producing Esclierichia coli and the infleunce of feeding ovalbumin. Int. Arch. Allergy Immunol. 105, 381-385.
99. Dakin, R. (1829). Remarks on a cutaneous affection produced by certain poisonous vegetables. Am. J. Med. Sci. 4, 98-100.
100. Dallman, M. J., Shiho, O., Page, T. H., Wood, K. J., and Morris, P. J. (1991). Peripheral tolerance to alloantigen results from altered regulation of the interleukin 2 pathway. J. Exp. Med. 173, 79-87.
101. Daniel, D., and Wegmann, D. R. (1996a). Intranasal administration of insulin peptide B:9-23 protects NOD mice from diabetes. Ann. iV.Y. Acad. Sci. 778, 371-372.
102. Daniel, D., and Wegmann, D. R. (1996b). Protection of nonobese diabetic mice from diabetics by intranasal or subcutaneous administration of insulin peptide B-(9-23). Proc. Natl. Acad. Sci. U.S.A. 93, 956-960.
103. Das, S., and Leskowitz, S. (1974). The cellular basis for tolerance or immunity to bovine gamma globulin in mice. J. Immunol. 112, 107-114.
104. Das, S., Di Padua, D., and Leskowitz, S. (1973). Tolerance induction with aggregated bovine gamma globulin in C57BIV6 mice. Proc. Soc. Exp. Biol. Mcd. 144, 373-375.
105. Daynes, R., Araneo, B., Dowell, T., Huang, K., and Dudley, D. (1990). Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function. J. Exp. Mcd. 171, 979-996.
106. Defrance, T., Vanbervliet, B., Brière, F., Durand, I., Rousset, F., and Banchereau, J. (1992). Interleukin 10 and transforming growth factor ßcooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J. Exp. Med. 175, 671-682.
107. DeKruyff, R. H., Rinnooy Kan, E. A., Weksler, M. E., and Siskind, G. W. (1980). Effect of aging on T-cell tolerance induction. Cell. Immunol. 56, 58-67.
108. DeSilva, D. R., Urdahl, K. B., and Jenkins, M. K. (1991). Clonal anergy is induced in citro by T-cell receptor occupancy in the absence of proliferation. J. Immunol. 147,3261-3267.
109. De Smedt, T., Van Mechelen, M., De Becker, G., Urbain, J., Leo, O., and Moser, M. (1997). Effect of interleukin-10 on dendritic cell maturation and function. Etir. J. Immunol. 27, 1229-1235.
110. + T-cell-depleted mice. Enr. J. Immunol., 26, 1756-1761.
111. De Vries, J. E. (1995). Immunosuppressive and anti-inflammatory properties of interleukin 10. Ann. Med. 27, 537-547.
112. Devey, M. E., and Bleasdale, K. (1984). Antigen feeding modifies the course of antigeninduced immune complex disease. Clin. Exp. Immunol. 56, 637-644.
113. Dighiero, G., Lim, A., Poncet, P., Kaushik, A., Ge, X. R., and Mazie, J. C. (1987). Agerelated natural antibody specificities among hybridoma clones originating from NZB spleen. Immunology 62, 341-347.
114. Doken, J., Weksler, M. E., and Siskind, G. W. (1980). Effect of age on ease of B-cell tolerance induction. Cell. Immunol. 55, 66-73.
115. Domen, P. L., Muckerheide, A., and Michael, J. G. (1987). Cationization of protein antigens. III. Abrogation of oral tolerance.J. Immunol. 139, 3195-3198.
116. Donnenberg, M. S., and Kaper, J. B. (1992). Enteropathogenic Escherichia coll. Infect. Immun. 60, 3953-3961.
117. Duchmann, R., Schmitt, E., Knolle, P., Meyer zum Buschenfelde, K. H., and Neurath, M. (1996). Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. Ear. J. Immunol. 26, 934-938.
118. Elliott, E. A., McFarland, H. I., Nye, S. H., Cofiell, R., Wilson, T. M., Willdns, J. A., Squinto, S. P., Matis, L. A., and Mueller, J. P. (1996). Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein. J. Clin. Invest. 98, 1602-1612.
119. Elson, C. O., and Balding, W. (1984a). Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen. J. Immunol. 133, 2S92-2897.
120. Elson, C. O., and Ealding, W. (1984b). Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J. Immunol. 132, 2736-2741.
121. Elson, C. O., Tomasi, M., Dertzbaugh, M. T., Thaggard, G., Hunter, R., and Weaver, C. (1996). Oral antigen delivery by way of a multiple emulsion system enhances oral tolerance. Ann. N.Y. Acad. Sci. 778, 156-162.
122. Enders, G., Gottwald, T., and Brendel, W. (1986). Induction of oral tolerance in rats without Peyer's patches. Immunology 58, 311-314.
123. Enomoto, A., Konishi, M., Hachimura, S., and Kaminogawa, S. (1993). Milk whey protein fed as a constituent of the diet induced both oral tolerance and a systemic humoral response, while heat-denatured whey protein induced only oral tolerance. Clin. Immunol. Immunopathol. 66, 136-142.
124. Everson, M. P., Lemak, D. G., McGhee, J. R., and Beagley, K. W. (1997). FACS-sorted spleen and Peyer's patch dendritic cells induce different responses in ThO clones. Adv. Exp. Med. Biol. 417, 357-362.
125. Falcone, M., and Bloom, B. R. (1997). A T helper cell 2 (Th2) immune response against non-self antigens modifies the cytokine profile of autoimmune T-cells and protects against experimental allergic encephalomyelitis. J. Exp. Med. 185, 901-907.
126. Faria, A. M. C., Maron, R., Komagata, Y., and Weiner, H. L. (1999). Continuous feeding of low dose ovalbumin enhances TGF-beta production by spleen cells of Balb/c, C57BL/6, and OVA TCR transgenic mice. FASEB J. 13(4), A608.
127. Faria, A. M. C., Ficker, S. M., Speziali, E., Menezes, J. S., Stransky, B., Verdolin, B. A., Lahmann, W. M., Rodrigues, V. S., and Vaz, N. M. (1998b). Aging and immunoglobulin isotype patterns in oral tolerance. Braz. J. Med. Biol. Res. 31, 35-48.
128. Faria, A. M., Ficker, S. M. Speziali, E., Menezes, J. S., Stransky B., Suva Rodrigues, V., and Vaz, N. M. (1998a). Aging affects oral tolerance induction but not its maintenance in mice. Mech. Ageing Dev. 102, 67-80.
129. Faria, A. M., Garcia, G., Rios, M. J., Michalaros, C. L., and Vaz, N. M. (1993). Decrease in susceptibility to oral tolerance induction and occurrence of oral immunization to ovalbumin in 20-38-week-old mice. The effect of interval between oral exposures and rate of antigen intake in the oral immunization. Immunology 78, 147-151.
130. Feldman, M., Brennan, F. M., and Maini, R. N. (1996). Role of cytokines in rheumatoid arthritis. Anna. Rev. Immunol. 14, 397-440.
131. Ferber, I., Schonrich, G., Schenke. J., Mellor, A. L., Hammerling, G., and Arnold, B. (1994). Science 263, 674-676.
132. Fishman-Lobell, J., Friedman, A., and Weiner, H. L. (1994). Different kinetic patterns of cytokine gene expression in vivo in orally tolerant mice. Eur. J. Immunol. 24,2720-2724.
133. Fitzpatrick, J. L., Bailey, M., Harbour, D. A., and Stokes, G. R. (1992). Comparison of antibody and cell-mediated immune responses in horses following feeding of a novel dietary antigen, ovalbumin, and rotavirus. Vet. Immtinol. Immunopathol. 34, 245-257.
134. Foo, M. C., and Lee, A. (1972). Immunological response of mice to members of the autochthonous intestinal microflora. Infect. Immun. 6, 525-532.
135. Freeman, G. J., Boussiotis, V. A., Anumanthan, A., Bernstein, G. M. Ke, K.-Y., Rennert, P. D., Gray, G. S., Gribben, J. G., and Nadler, L. M. (1995). B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 2, 523-532.
136. Friedman, A., and Weiner, II. ( 1994). Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc. Natl. Acad. Sei. U.S.A. 91, 6688-6692.
137. +) T-cell abrogate oral tolerance while α/β TCR T-cells provide B cell help. J. Exp. Med. 175, 695-707.
138. Fujihashi, K., McGhee, J. R., Yamamoto, M., Hiroi, T. and Kiyono, H. (1996). Role of gamma delta T-cells in the regulation of mucosal IgA response and oral tolerance. Ann. N.Y. Acad. Sei. 778, 55-63.
139. Fujiwara, H., Qian, J. H., Satoh, S., Kokudo, S., Ikegami, R., and Hamaoka, T. (1996). Studies on the induction of tolerance to alloantigens. II. The generation of serum factor(s) able to transfer alloantigen-specific tolerance for delayed-type hypersensitivity by portal venous inoculation with allogeneic cells. J. Itmnunol. 136, 2763-2768.
140. Fukaura, II., Kent, S. C., Pietrusewicz, M. J., Klioury, S. J., Weiner, IL L., and Hafier, D. A. (1996). Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-betal-secreting Th3 T-cells by oral administration of myelin in multiple sclerosis patients. J. Clin. Invest. 98, 70-77.
141. Fuller, K. A., Pearl, D., and Whitacre, C. C. (1990). Oral tolerance in experimental autoimmune encephalomyelitis: Serum and salivary antibody responses. J. Neiiroimmunol. 28, 15-26.
142. Furrie, E., Turner, M. W., and Storbel, S. (1994). Failure of SCID mice to generate an oral tolerogen after a feed of ovalbumin: A role for a functioning gut-associated lymphoid system. Immunology 83, 562-567.
143. Furrie, E., Turner, M., and Strobel, S. (1995a). The absence of gut flora has no effect on the induction of oral tolerance to ovalbumin. Ado. Exj). Med. Biol. 1239-1241.
144. Furrie, E., Turner, M. W., and Strobel, S. (1995b). Partial characterization of a circulating tolerogenic moiety which, after a feed of ovalbumin, suppress delayed-type hypersensitivity in recipient mice. Immunology 86, 480-486.
145. Gaboriau-Routhiau, V., and Moreau, M. (1996). Gut flora allows recovery of oral tolerance to ovalbumin in mice after transient breakdown mediated by cholera toxin and Escherichia coli heat-labile enterotoxin. Pediatr. Res. 39, 625-629.
146. Galliaerde, V., Desvignes, C., Peyron, E., and Kaiserlian, D. (1995). Oral tolerance to haptens: Intestinal epithelial cells from 2,4-dinitrochlorobenzene-fed mice inhibit haptenspecific T-cell activation in vitro. Eur. J. Itmnunol. 25, 1385-1390.
147. Gammon, G., and Sercaz, E. (1989). Nature (London) 342, 183-185.
148. Gaupp, S., Härtung, H. P., Toyka, K., and Jung, S. (1997). Modulation of experimental autoimmune neuritis in Lewis rats by Oral application of myelin antigens.J. Neuroimmunol. 79, 129-137.
149. Gaur, A., Wiers, B., Liu, A., Rothbard, J., and Fathman, C. G. (1992). Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy. Science 258, 1491-1494.
150. Gautam, S. C., and Battisto, J. R. (1985). Orally induced tolerance generates an eflerently acting suppressor T-cell and an acceptor T-cell that together down-regulate contact sensitivty.J. Immunol. 135, 2975-2983.
151. Gautam, S. C., Chikkala, N. F., and Battisto, J. R. (1990). Oral administration of the contact sensitizer trinitrochlorobenzene: Initial sensitization and subsequent appearance of a suppressor population. Cell Immunol. 125, 437-448.
152. Gesualdo, L., Lamm, M. E., and Emancipator, S. N. (1990). Defective oral tolerance promotes nephritogenesis in experimental IgA nephropathy induced by oral immunization. ). Immunol. 145, 3684-3691.
153. Goidl, E. A., Thorbecke, G. J., Weksler, M. E., and Siskind, G. W. (1980). Production of auto-anti-idiotypic antibody during the normal immune response: Changes in the autoanti-idiotypic antibody response and the idiotype repertoire associated with aging. Proc. Natl. Acad. Sei. U.S.A., 77, 6788-6792.
154. Gold, W. R., Jr., Queenan, J. T., Woody, J., and Sacher, R. A. (1983). Oral desensitization in Rh disease. Am. J. Obstet. Gynecol. 146, 980-981.
155. Goldman-Brezinski, S., Brezinski, K., Zhang, X. M., Gienapp, I., Cox, K., Heber-Katz, E., and Whitacre, C. (1998). Effects of oral tolerance induction by myelin basic protein on Vbeta8+ Lewis rat T-cells. J. Neurosci. Res. 51, 67-75.
156. Gonnella, P. A., Chen, Y., Inobe, J.-I., Quartulli, M., and Weiner, H. L. (1998). In situ immune response in gut associated lymphoid tissue (GALT) following oral antigen in TcR transgenic mice. J. Immunol. 160, 4708-4718.
157. + T-cells. Immunology 81, 27-35.
158. Gorczynski, R. M., Hozumi, N., Wolf, S., and Chen, Z. (1995). Interleukin 12 in combination with anti-interleukin 10 reverses graft prolongation after portal venous immunization. Transplantion 60, 1337-1341.
159. Gorczynski, R. M., Chen, Z., Hoang, Y., and Rossi-Bergman, B. (1996). A subset of gamma delta T-cell receptor-positive cells produce T-helper type-2 cytokines and regulate mouse skin graft rejection following portal venous pretransplant preimmunization. Immunology 87, 381-389.
160. Grdic, D., Hornquist, E., Kjerrulf, M., and Lycke, N. Y. (1998). Lack of local suppression in orally tolerant CDS-deficient mice reveals a critical regulatory role of CD8+T-cells in the normal gut mucosa. J. Immunol. 160, 754-762.
161. Gregerson, D. S., Obritsch, W. F., and Donoso, L. A. (1993). Oral tolerance in experimental autoimmune uveoretinitis. Distinct mechanisms of resistance are induced by low dose vs high dose feeding protocols.J. Immunol. 151, 5751-5761.
162. Gregorian, S. K., Clark, L., Heber-Katz, E., Amento, E. P., and Rostami, A. (1993). Induction of peripheral tolerance with peptide-specific anergy in experimental autoimmune neuritis. Cell. Immunol. 150, 298-310.
163. Groux, H., O'Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J. E., and Roncarolo, M. G. (1997). A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature (London) 389, 737-742.
164. Guimaraes, V. C., Quintans, J., Fisfalen, M.-E., Straus, F. H., Wilhelm, K., Medeiros-Neto, G. A., and DeGroot, L. J. (1995). Suppression of experimental autoimmune thyroiditis by oral administration of thyroglobulin. Endocrinology 136, 3353-3359.
165. Guimaraes, V. C., Quintans, J., Fisfalen, M. E., Straus, F. H., Fields, P. E., MedeirosNeto, G., and DeGroot, L. J. (1996). Immunosuppression of thyroiditis. Endocrinology 137, 2199-2204.
166. Giitgemann, L, Fahrer, A. M., Altman, J. D., Davis, M. M., and Chien, Y. (1998). Induction of rapid T-cell activation and tolerance by systemic presentation of an orally administered antigen. Immunity 8, 667-673.
167. Habicht, G. S. (1980). Tolerance to human IgG in aged C57BL/6 and BALB/c mice. Fed. Proc. 39, 2118-2124.
168. Hachimura, S., Fujikawa, Y., Enomoto, A., Kim, S. M., Ametani, A., and Kaminogavva, S. (1994). DilTerential inhibition of T and B cell responses to individual antigenic determinants in orally tolerized mice. Int. Immunol. 6, 1791-1797.
169. Hag, T. A., Mason, H. S., Clements, J. D., and Arntzen, C. J. (1995). Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science 268,714-716.
170. Halsey, J. F., and Benjamin, D. C. (1976). Induction of immunologie tolerance in nursing neonates by absorption of tolerogen from colostrum.J. Immunol. 116, 1204-1207.
171. Hancock, W., Sayegh, M., Kwok, C., Weiner, H., and Carpenter, C. (1993). Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation. Transplantion 55, 1112-1118.
172. Hancock, W. W., Khoury, S. J., Carpenter, C. B., and Sayegh, M. II. (1994). Differential effects of oral versus intrathymic administration of polymorphic major histocompatibility complex class II peptides on mononuclear and endothelial cell activation and cytokine expression during a delayed-type hypersensitivity response. Am.J. Patliol. 144,1149-1158.
173. Hancock, W. W., Polanski, M., Zhang, Z. J., Blogg, N., and Weiner, H. L. (1995). Suppression of insulitis in NOD mice by oral insulin administration is associated with selective expression of IL-4, IL-10, TGF-β and prostaglandin-E. Am. J. Pathol. 147, 1193-1199.
174. Haneda, K., Sano, K., Tamura, G., Sato, T., Habu, S., and Shiratô, K. (1997). TGF-β induced by oral tolerance ameliorates experimental trachea! eosinophilia. J. Immunol. 159, 4484-4490.
175. Hanson, D. G. (1981). Ontogeny of orally induced tolerance to soluble proteins in mice. I. Priming and tolerance in newborns. J. Immunol. 127, 1518-1524.
176. Hanson, D. G., and Miller, S. D. (1982). Inhibition of specific immune responses by feeding protein antigens. V. Induction of the tolerant state in the absence of specific suppressor T-cells. J. Immunol. 128, 2378-2381.
177. Hanson, D. G., and Morimoto, T. (1987). Delayed recovery of orally-induced tolerance to proteins in irradiated and spleen-cell reconstituted mice. Ado. Exp. Med. Biol. 216A, 733-738.
178. Hanson, D. G., Vaz, N. M., Maia, L. C., Hombrook, M. M., Lynch, J. M., and Roy, C. A. (1977). Inhibition of specific immune responses by feeding protein antigens. Int. Arch. Allergy Appl. Immunol. 55, 526-532.
179. Hanson, D. G., Vaz, N. M., Maia, L. C., and Lynch, J. M. (1979a). Inhibition of specific immune responses by feeding protein antigens. III. Evidence against maintenance of tolerance to ovalbumin.by orally induced antibodies.J. Immunol. 123, 2337-2343.
180. Hanson, D. G., Vaz, N. M., Rawlings, L. A., and Lynch, J. L. (1979). Inhibition of specific immune responses by feeding protein antigens. II. Effects of prior passive and active immunization. J. Immunol. 122, 2261-2266.
181. Hanson, D. G., Roy, M. J., Green, G. M., and Miller, S. D. (1993). Inhibition of orally-induced immune tolerance in mice by prefeeding an endopeptidase inhibitor. Reg. Immunol. 5, 76-84.
182. Haque, M. A., Yoshino, S., Inada, S., Nomaguchi, H., Tokunaga, O., and Kohashi, O. (1996). Suppression of adjuvant arthritis in rats by induction of oral tolerance to mycobacterial 65-kDa heat shock protein. Eur. J. Immunol. 26, 2650-2656.
183. Harper, H. M., Cochrane, L., and Williams, N. A. (1996). The role of small intestinal antigen-presenting cells in the induction of T-cell reactivity to soluble protein antigens: Association between aberrant presentation in the lamina propria and oral tolerance. Immunology 89, 449-456.
184. Harrison, L. C. (1992). Islet cell antigens in insulin-dependent diabetes: Pandora's box revisited. Immimol. Today 13, 348-352.
185. Harrison, L. C., Dempsey-Collier, M., Kramer, D. R., and Takahashi, K. (1996). Aerosol insulin induces regulatory CDS γ δ T-cells that prevent murine insulin-dependent diabetes. J. Exp. Med. 184, 2167-2174.
186. Hartmann, B., Bellman, K., Ghiea, L, Kleeman, R., and Kolb, H. (1997). Oral insulin for diabetes prevention in NOD mice: Potentiation by enhancing Tb2 cytokine expression in the gut through bacterial adjuvant. Diabetology 40, 902-909.
187. He, Y. G., Mellon, J., and Niederkom, J. Y. (1996). The effect of oral immunization on corneal allograft survival. Transplantion 61, 920-926.
188. Hemmings, W. A. (1978). "Antigen Absorption by the Gut." MTP Press, Lancaster.
189. Heppell, L. M. J., and Kilshavv, P. J. (1982). Immune responses in guinea pigs to dietary protein. Int. Arch. Allergy Appl. Immunol. 68, 54-59.
190. + thymocytes expressing L-selectin mediate active tolerance in the nonobese diabetic mouse.J. Immunol. 161, 2620-2628.
191. Higgins, P., and Weiner, H. L. (1988). Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J. Immunol. 140, 440-445.
192. Hiroi, T., Iwatani, K., lijima, IL, Kodama, S., Yanagita, M., and Kiyono, H. (1998). Nasal immune system: Distinctive ThO and Thl/Th2 type environments in murine nasalassociated lymphoid tissues and nasal passage, respectively. Eur. J. Immunol. 28, 3346-3353.
193. Holt, P. G., and Sedgwick, J. D. (1987). Suppression of IgE responses following inhalation of antigen. Immunol. Today 8, 14-15.
194. Holt, P. G., Batty, J. E., and Turner, K. J. (1981). Inhibition of specific IgE response in mice by pre-exposure to inhaled antigen. Immunology 42, 409-417.
195. Holt, P. G., Vines, J., and Britten, D. (1988). Sublingual allergen administration. I. Selective suppression of IgE production in rats by high allergen doses. Clin. Allergy 18, 229-234.
196. Hormatz, P. R., Bloch, K. J., Brown, M., Walker, W. A., and Kleinam, R. E. (1989). Intestinal adaptation during lactation in the mouse. 1. Enhanced intestinal uptake of dietary protein antigens. Immunology 67, 551-555.
197. Hoyne, G. F., and Lamb, J. R. (1997). Regulation of T-cell function in mucosal tolerance. Immunol. Cell Biol. 75, 197-201.
198. Hoyne, G. F., and Thomas, W. R. (1995). T-Cell responses to orally administered antigens. Study of the kinetics of lymphokine production after single and multiple feeding. Immunology 84, 304-309.
199. Hoyne, G. F., O'Hehir, R. E., Wraith, D. C., Thomas, W. R., and Lamb, J. R. (1993). Inhibition of T-cell and antibody responses to house dust mite allergen by inhalation of the dominant T-cell epitope in naive and sensitized mice.J. Exp. Med. 178, 1783-1788.
200. Hoyne, G. F., Callow, M. G., Kuo, M. C., and Thomas, W. R. (1994). Differences in epitopes recognized by T-cells during oral tolerance and priming. Immunol. Cell Biol. 72, 29-33.
201. Hoyne, G. F., Askinas, B. A., Hetzel, C., Thomas, W. R., and Lamb, J. R. (1996). Regulation of house dust mite responses by intranasally administered peptide: Transient activation of CD4+ T-cells precedes the development of tolerance in vivo. Int. Immunol. 8,335-342.
202. Hoyne, G. F., Jarnicki, A. G., Thomas, W. R., and Lamb, J. R. (1997). Characterization of the specificity and duration of T-cell tolerance to intranasally administered peptides in mice: A role for intramolecular epitope suppression. Int. Immunol. 9, 1165-1173.
203. Hu, W., Hasan, A., Wilson, A., Stanford, M., Li-Yang, Y., Todryk, S., Whiston, R., Shinnick, T., Mizushima, Y., van der Zee, R., and Lehner, T. (1998). Experimental mucosal induction of uveitis with the 60-kDa heat shock protein-derived peptide 336-351. J. Immunol. 28, 2444-2455.
204. Huang, L., Soldevila, G., Leeker, M., Flavell, R., and Crispe, I. N. (1994). The liver eliminates T-cells undergoing antigen-triggered apoptosis in vivo. Immunity 1, 741-749.
205. Huetz, F., Tai Korn, Y., and Coutinho, A. (1990). Cellular basis for the age-associated increase in autoimmune reactions. Int. Immunol. 2, 329-335.
206. Husby, S., Jensenius, J. C., and Svehag, S. E. (1985a). Passage of undergraded dietary antigen into the blood of healthy adults. Scand. J. Immunol 22, 83-92.
207. Husby, S., Oxelius, V. A., Teisner, B., Jensenius, J. C., and Svehag, S. E. (1985b). Humoral immunity to dietary antigens in healthy adults. Int. Arch. Allergy Immunol. 77,416-422.
208. Husby, S., Mestecky, J., Moldoveanu, Z., Holland, S., and Elson, C. O. (1994). Oral tolerance in humans. T-cell but not B cell tolerance after antigen feeding.J. Immunol. 152,4663-4670.
209. lijima, H., Takahashi, I., Hiroi, T., Shimaoka, M., Kawano, S., Nagano, K., Hori, M., and Kiyono, H. (1998). Orally administered cholera toxin prevents murine intestinal T cells from staphylococcal enterotoxin B-induced anergy. Gastroenterology 115, 1197-1204.
210. Ilan, Y., Prakash, R., Davidson, A., Jona, V., Droguett, G., Horwitz, M. S., Chowdhury, N. R., and Chowdhury, J. R. (1997). Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectors.J. Clin. Invest. 99,1098-1106.
211. Imaoka, K., Miller, C. J., Kubota, M., McChesney, M. B., Lohman, B., Yamamoto, M., Fujihashi, K., Someya, K., Honda, M., McGhee, J. R., and Kiyono, H. (1998). Nasal immunization of nonhuman primates with simian immunodeficiency virus pSSgag and cholera toxin adjuvant induces Thl/Th2 help for virus-specific immune responses in reproductive tissues. J. Immunol. 161, 5952-5958.
212. Inada, S., Yoshino, S., Haque, M. A., Ogata, Y., and Kohashi, O. (1997). Clonal anergy is a potent mechanism of oral tolerance in the suppression of acute antigen-induced arthritis in rats by oral administration of the inducing antigen. Cell. Immunol. 175, 67-75.
213. Inobe, J., Slavin, A. J., Komagata, Y., Chen, Y., Liu, L., and Weiner, H. L. (1998). IL-4 is a differentiation factor for transforming growth factor-beta secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis. Eur. J. Immunol. 28, 2780-2790.
214. Insoft, R. M., Sanderson, I. R., and Walker, W. A, (1996). Development of immune function in the intestine and its role in neonatal diseases. Pediatr. Clin. Nortli Am. 43, 551-571.
215. Ishii, N., Moriguchi, N., Sugita, Y., Nakajima, H., Tanaka, S., and Aoki, I. (1993). Analysis of responsive cells in tolerance by the oral administration of ovalbumin. Immunol. Invest. 22, 451-462.
216. Ishizaka, S., Kimoto, M., Tsujii, T., and Saito, S. (1994). Antibody production system modulated by oral administration of human milk and TGF-β. Cell. Immunol. 159,77-84.
217. Iwasaki, A., and Kelsall, B. L. (1999). Distinct T cell priming by freshly isolated dendritic cells from Peyer's patch and spleen. FASEB J. 13(4), A606.
218. Jacobs, M. J. M., Van Den Hoek, A. E. M., Van De Putte, L. B. A., and Van Den Berg, W. B. (1993). Aberrant tolerance induction with cationic antigens. Scand. J. Immunol. 37, 97-103.
219. Jain, S. L., Barone, K. S., and Michael, J. G. (1996). Activation patterns of murine T-cells after oral administration of an enterocoated soluble antigen. Cell. Immunol. 167,170-175.
220. Jarrett, E. E. (1984). Perinatal influences on IgE responses. Lancet 2, 797-799.
221. Javed, N. II., Gienapp, I. E., Cox, K. L., and Whitacre, C. C. (1995). Exquisite peptide specificity of oral tolerance in experimental autoimmune encephalomyelitis. J. Immunol. 155, 1599-1605.
222. Jewell, S., Dierksheide, J., Cuny, A., Shrestha, A., and Waldman, J. (1998). Suppression of experimental autoimmune encephalomyelitis (EAE) by portal vein (PV) injection of myelin basic protein (MBP). FASEB J. 12, A600.
223. Josien, R., Douillard, P., Guillot, G., Müschen, M., Anegon, I., Chetritt, J., Menoret, S., Vignes, C., Soulillou, J. P., and Cuturi, M. C. (1998). A critical role for transforming growth factor-β in donor transfusion-induced allograft tolerance. J. Clin. Invest. 102,1920-1926.
224. Kagnoff, M. F. (1978a). Effects of antigen-feeding on intestinal and systemic immune responses. II. Suppression of delayed-type hypersensitivity reactions. J. Immunol. 120, 1509-1513.
225. Kagnoff, M. F. (1978b). Effects of antigen-feeding on intestinal and systemic immune responses. III. Antigen-specific serum-mediated suppression of humoral antibody responses after antigen feeding. Cell. Immunol. 40, 186-203.
226. a. Eur. J. Immunol. 23, 2717-2720.
227. Kalanadhabhatta, V., Muppidi, D., Salmi, IL, Rubles, A., and Kramer, M. (1996). Successful oral desensitization to trimethoprim-sulfamethoxazole in acquired immune deficiency syndrome. Ann. Allergy Asthma Immunol. 77, 394-400.
228. Kalinski, P., Hilkens, C. M., Snijders, A., Snijdewint, F. G., and Kapsenberg, M. L. (1997). IL-12 deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells. J. Immunol. 159, 28-35.
229. Kaltreider, II. B. (1976). Expression of immune mechanisms in the lung. Am. Rev. Respir. Dis. 113, 347-379
230. Kamada, N., Davies, H. S., and Roser, B. (1981). Nature (London) 292, 840-842.
231. Kamada, N., Teramoto, K., Baguerizo, A., Ishikawa, M., Sumimoto, R., and Olikouchi, Y. (1988). Cellular basis of transplantation induced by liver grafting in the rat. Extent of clonal deletion among thoracic duct lymphocytes, spleen, and lymph node cells. Transplantion 46, 165-167.
232. Kaneko, T., Terasawa, Y., Senou, Y., Nagata, M., and Kuwata, T. (1998). Oral tolerance is not influenced by oral application of oil-emulsified proteins. Int. Arch. Allergy Immunol. 116, 81-82.
233. Kantele, A., and Makela, P. II. (1991). Different profiles of the human immune response to primary and secondary immunization with an oral Salmonella typhi Ty21a vaccine. Vaccine 9, 423-427.
234. Kapp, J. A., and Ke, Y. (1997). The role of gamma delta TCR-bearing T cells in oral tolerance. Res. Immunol. 148, 561-567.
235. Karachunski, P. I., Ostlie, N. S., Okita, D. K:, and Conti-Fine, B. M. (1997). Prevention of experimental myasthenia gravis by nasal administration of synthetic acetylcholine receptor T epitope sequences. J. Clin. Invest. 100, 3027-3035.
236. Karpus, W. J., and Lukacs, N. W. (1996). The role of chemokines in oral tolerance: Abrogation of nonresponsiveness by treatment with antimonocyte chemotactic protein-1. Ann. N.Y. Acad. Sei. 778, 133-144.
237. Karpus, W., Kennedy, K., Smith, W., and Miller, S. (1996). Inhibition of relapsing experimental autoimmune encephalomyelitis in SJL mice by feeding the immunodominant PLP139-151 peptide. J. Neurosci. Res. 45, 410-423.
238. Karpus, W. J., Kennedy, K. J., Kunkel, S. L., and Lukacs, N. W. (1998). Monocyte chemotactic protein 1 regulates oral tolerance induction by inhibition of T helper cell-related cytokines. J. Exp. Med. 187, 733-741.
239. Kawanishi, IL, and Kiely, J. (1987). Immunoregulatory defects in murine aged Peyer's patches. Eur. J. Immunol. 17, 1223-1228.
240. Kawanishi, H., Senda, S., and Ajitsu, S. (19S9). Aging-associated intrinsic defects in IgA production by murine Peyer's patch B cells stimulated by autoreactive Payer's patch Tcell hybridoma-derived B cell stimulatory factors (BSF). Mech. Aging Dcv. 49, 61-78.
241. Kay, R. A., and Ferguson, A. (19S9). The immunological consequences of feeding cholera toxin. I. Feeding cholera toxin suppresses the induction of systemic delayed-type hypersensitivity but not humoral immunity. Immunology 66, 410-415.
242. + suppressor T-cells. J. Immunol. 156, 916-921.
243. Ke, Y., Pearce, K., Lake, J. P., Ziegler, H. K., and Kapp, J. A. (1997). Gamma delta T lymphocytes regulate the induction and maintenance of oral tolerance. J. Immunol. 158, 3610-3618.
244. Kelly, K. A., and Whitacre, C. C. (1996). Oral tolerance in EAE: Reversal of tolerance by T helper cell cytokines. J. Neuroimmunol. 66, 77-84.
245. Kerlero de Rosbo, N., Milo, R., Lees, M. B., Burger, D., Bernard, C. C. A., and Ben-Nun, A. (1993). Reactivity to myelin antigens in multiple sclerosis: Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoproteîn.J. Clin. Invest, 92,26022608.
246. Khare, S. D., Krco, C. J., Griffiths, M. M., Luthra, II. S., and David, C. S. (1995), Oral administration of an immunodominant human collagen peptide modulates collageninduced arthritis. J. Immunol. 155, 3653-3659.
247. Khoury, S. J., Lider, O., al-Sabbagh, A., and Weiner, H. L. (1990). Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. III. Synergistic effect of lipopolysaccharide. Cell. Immunol. 131, 302-310.
248. Khoury, S. J., Hancock, W. W., and Weiner, II. L. (1992). Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis as associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor ß, interleukin 4, and prostaglandin E expression in the brain. J. Exp. Med. 176, 1355-1364.
249. Khoury, S. J., Sayegh, M. IL, Hancock, W. W., Gallon, L., Carpenter, C. B., and Weiner, H. L. (1993). Acquired tolerance to experimental autoimmune encephalomyelitis by intrathymic injection of myelin basic protein or its major encephalitogenic peptide. J. EI;J. Med. 178, 559-566.
250. Kilshaw, P. J., and Cant, A. J. (19S4). The passage of maternal dietary proteins into human breast milk. Inf. ArcJi. Allergy Aml. Immunol. 75, 8-15.
251. Kim, J. IL, and Ohsawa, M. (1995). Oral tolerance to ovalbumin in mice as a model for detecting modulators of the immunologie tolerance to a specific antigen. Biol. Phann. Bull. 18, 854-858.
252. Kim, S. M., Enomoto, A., Hachimura, S., Yamauchi, K., and Kaminogawa, S. (1993). Serum antibody response elicited by a casein diet is directed to only limited determinants of alpha si-casein. Int. Arch. Allergy Immunol. 101, 260-265.
253. Kim, S. K., Reed, D. S., Olson, S., Schnell, M. J., Rose, J. K., Morton, P. A., and Lefrancois, L. (1998). Generation of mucosal cytotoxic T-cells against soluble protein by tissue-specific environmental and costimulatory signals. Proc. Natl. Acad. Sei. U.S.A. 95, 10814-10819.
254. King, C., Davics, J., Mueller, R., Lee, M. S., Kralil, T., Yeung, B., O'Connor, E., and Sarvetnick, N. (1998). TGF-β-1 alters APC preference, polarizing islet antigen responses toward a Th2 phenotype. Immunity 8, 601-613.
255. Kiyono, IL, McGhee, J. R., Wannemuehler, M. J., and Michalek, S. M. (1982). Lack of oral tolerance in C3H/HeJ mice. J. Exp. Med. 155, 605-610.
256. Kjernilf, M., Grelle, D., Ekman, L., Schon, K., Vajdy, M., and Lycke, N. Y. (1997). Interferongamma receptor-deficient mice exhibit impaired gut mucosal immune responses but intact oral tolerance. Immunology 92, 60-68.
257. Komagata, Y., Liu, L. M., and Weiner, H. L. (1998). B cells are important for the production of active TGF-0. FASEB J. I, A30S.
258. Korenblatt, P. E., Rothberg, R. M., Minden, P., and Farr, R. S. (1968). Immune responses of human adults after oral and parenteral exposure to bovine serum albumin. J. Allergy Clin. Immunol. 41, 226-235.
259. Kosiewicz, M. M., Alard, P., and Streilein, J. W. (1998). Alterations in cytokine production following intraocular injection of soluble protein antigen: Impairment in IFN-gamma and induction of TGF-beta and IL-4 production.J. Immnnol. 161, 5382-5390.
260. Koster, F. T., and Pierce, N. F. (1983). Parenteral immunization causes antigen-specific cell-mediated suppression of an intestinal IgA response.J. Immnnol. 131, 115-118.
261. Koyama, K., Hosokawa, T., and Aoike, A. (1990). Aging effect on the immune function of murine gut-associated lymphoid tissues. Dcv. Comp. Immnnol. 14, 465-473.
262. Kuchroo, V. K., Byme, M. C., Atsumi, Y., Greenfield, E., Connolly, J. B., Whitters, M. J., O'Hara, R., Jr., Collins, M., and Dorf, M. E. (1991). T-cell receptor alpha chain plays a critical role in antigen-specific suppressor cell function. Proc. Natl. Acad. Sei. U.S.A. 88, 8700-8704.
263. Kulm, R., Lohler, J., Rennick, D., Rajewsky, K., and Muller, W.- (1993). Interleukin-10 deficient mice develop chronic enterocolitis. Cell 75, 263-274.
264. Kunimoto, D. Y., Harriman, G. R., and Strober, W. (1988). Regulation of IgA differentiation in CH12LX B cells by lymphokines. IL-4 induces membrane IgM-positive CH12LX cells to express membrane IgA and IL-5 induces membrane IgA-positive CII12LX cells to secrete IgA.J. Immunol. 141, 713-718.
265. Kuper, C. F., Koornstra, P. J., Hameleers, D. M., Biewenga, J., Spit, B. J., Duivestijn, A. M., van Breda Vriesman, P. J., and Sminia, T. (1992). The role of nasopharyngeal lymphoid tissue. Immunol. Today 13, 219-224.
266. Kweon, M. N., Fujihashi, K., Wakatsuki, Y., Koga, T., Yamamoto, M., McGhcc, J. R., and Kiyono, H. (1999). Mucosally induced systemic T cell unresponsiveness to ovalbumin requires CD40 ligand-CD40 interactions. J. Immnnol. 162(4), 1904-1909.
267. Kweon, M., Fujihashi, K., VanCott, J., Higuchi, K., Yamamoto, M., McGhee, J., and Kiyono, H. (1998). Lack of orally induced systemic unresponsiveness in IFN-gamma knockou mice. J. Immunol. 160, 1687-1693.
268. Lafont, S., Andre, C., Andre, F., Gillon, J., and Fargier, M.-C. (1982). Abrogation by subsequent feeding of antibody response, including IgE, in parenterally immunized mice. J. Exp. Med. 155, 1573-1578.
269. Lahmann, W. M., Menezes, J. S., Verdolin, B'. A., and Vaz, N. M. (1992). Influence of age on the induction of oral tolerance in mice and its adoptive transfer by spleen cells. Bra; J. Ucd. Biol. Res. 25, 813-821.
270. Lamont, A. G., Gordon, M., and Ferguson, A. (1987). Oral tolerance in protein-deprived mice. I. Profound antibody tolerance but impaired DTH tolerance after antigen feeding. Immunology 61, 333-337.
271. Lamont, A. G., Bruce, M. G., Watret, K. C., and Ferguson, A. (1988a). Suppression of an established DTH response to ovalbumin in mice by feeding antigen after immunization. Immunology 64, 135-139.
272. Lamont, A. G., Mowat, A. M., Browning, M. J., and Parrott, D. M. (1988b). Genetic control of oral tolerance to ovalbumin in mice. Immunology 63, 737-739.
273. Lamont, A. G., Mowat, A. M., and Parrot, D. M. V. (19S9). Priming of systemic and local delayed-type hypersensitivity responses by feeding low doses of ovalbumin to mice. Immunology 66, 595-599.
274. Lee, S., Scherberg, N., and De Groot, L. J. (1998). Induction of oral tolerance in human autoimmune thyroid disease. Thyroid 8, 229-234.
275. Leishman, A. J., Garside, P., and Mowat, A. M. (1998). Immunological consequences of intervention in established immune responses by feeding protein antigens. Cell. Immnnol. 183, 137-148.
276. + Tcell activation is mediated through CDS and the activation of CDS-associated p56. J. Exp. Med. 182, 1079-1088.
277. Li, H. L., Liu, J. Q., Bai, X. F., van der Meide, P. H., and Link, H. (1998a). Dose-dependent mechanisms relate to nasal tolerance induction and protection against experimental autoimmune encephalomyelitis in Lewis rats. Immunology 94, 431-437.
278. Li, H. L., Shi, F. D., Bai, X. F., Huang, Y. M., van der Meide, P. IL, Xiao, B. G., and Link, H. (1998b). Nasal tolerance to experimental autoimmune myasthenia gravis: Tolerance reversal by nasal administration of minute amounts of interferon-gamma. Clin. Immnnol. Imnmnopathol. 87, 15-22.
279. + T lymphocytes. J. Immunol. 142, 748-752.
280. Lippard, V. W., Schloss, O. M., and Johnson, P. A. (1936). Immune reactio'ns induced in infants by intestinal absorption of incompletely digested cow's milk protein. Am. J. Dis. Child. 52.
281. Litwin, A., Flanagan, M., Entis, G., Gottschlich, G., Esch, R., Gartside, P., and Michael, J. G. (1996). Immunologie effects of encapsulated short ragweed extract: A potent new agent for oral immunotherapy. Ann. Allergy Asthma Immnnol. 77, 132-138.
282. Litwin, A., Flanagan, M., Entis, G., Gottschlich, G., Esch, R., Gartside, P., and Michael, J. G. (1997). Oral immunotherapy with short ragweed extract in a novel encapsulated preparation: A double-blind study. J. Allergy Clin. Immnnol. 100, 30-38.
283. Liu, Y., and Janeway, C. A. (1990). Interferon y plays a critical role in induced cell death of effector cell: A possible third mechanism of self-tolerance.J. Exp. Mcd. 172,1735-1739.
284. Liu, L. M., and MacPherson, G. G. (1993). Antigen acquisition by dendritic cells: Intestinal dendritic cells acquire antigen administered orally and can prime naive T-cells in vivo. J. Exp. Mcd. 177, 1299-1307.
285. Liu, J. Q., Bai, X. F., Shi, F. D., Xiao, B. G., Li, H. L., Levi, M., Mustafa, M., Wahren, B., and Link, H. (1998a). Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: Synergistic effects of MBP 68-86 and 87-99. Int. Immnnol. 10, 11391148.
286. Liu, L., Kuchroo, V. K., and Weiner, II. L. (1998b). B7.2 but not B7.1 costimulation is required for the induction of low dose oral tolerance. FASEB J. I, A597.
287. + T-cells to secrete interleukin-4. Int. Immunol. 10, 1017-1026.
288. Louis, E., Franchimont, D., Deprez, M., Lamproye, A., Schaaf, N., Mahieu, P., and Belaiche, J. (1996). Decrease in systemic tolerance to fed ovalbumin in indomethacin-treated mice. Int. Arch. Allergy Immunol. 109, 21-26.
289. Lown, K. S., Bailey, D. G., Fontana, R. J., Janardan, S. K., Adair, C. H., Fortlage, L. A., Brown, M. B., Guo, W., and Watkins, P. B. (1997). Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression. J. Clin. Invest. 99, 2545-2553.
290. Lowney, E. D. (1968). Immunologie unresponsiveness to a contact sensitizer in man. J. Invest. Dennatol. 51, 411-417.
291. Lowney, E. D. (1971). Tolerance of dinitrochlorobenzene, a contact sensitizer, in man. J. Allergy Clin. Immiinol. 48, 28-35.
292. Lowney, E. D. (1973). Suppression of contact sensitization in man by prior feeding of antigen. J. Invest. Dennatol. 61, 90-93.
293. Lowney, E. D. (1974). A single-step procedure for inducing partial tolerance of DNCB in human subjects. J. Invest. Dermatol. 63, 260-261.
294. Lowrey, J. A., Savage, N. D. L., Palliser, D., Corsin-Jimenez, M., Forsyth, L. M. G., Hall, G., Lindey, S., Stewart, G. A., Tan, K. A. L., Hoyne, G. F., and Lamb, J. R. (1998). Induction of tolerance via the respiratory mucosa. Int. Arch. Allergy Immtinol. 116, 93-102.
295. Lu, S., and Holmdahl, R. (1999). Different therapeutic and bystander effects by intranasal administration of homologous type II and type IX collagens on the collagen-induced arthritis and pristance-induced arthritis in rats. Clin Immunol. 90, 119-127.
296. Lundin, B. S., Dahlgren, U. I. H., Hanson, L. A., and Telemo, E. (1996). Oral tolerization leads to active suppression and bystander tolerance in adult rats while anergy dominates in young rats. Scand. J. Immtinol. 43, 56-63.
297. Lycke, N., and Hohngren, J. (1986). Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunology 59, 301-308.
298. Ma, C.-G., Zhang, G.-X., Xiao, B.-G., Link, J., Olsson, T., and Link, II. (1995). Suppression of experimental autoimmune myasthenia gravis by nasal administration of acetylcholine receptor. J. Nenroimmtinol. 58, 51-60.
299. Ma, C. G., Zhang, G. X., Xiao, B. G., and Link, H. (1996). Cellular mRNA expression of interferon-gamma (IFN-y), IL-4 and transforming growth factor-beta (TGF-β) in rats nasally tolerized against experimental autoimmune myasthenia gravis (EAMG). Clin. Exp. Immtinol. 104, 509-516.
300. Ma, D., Mellon, J., and Niederkorn, J. Y. (1997a). Oral administration as a strategy for enhancing corneal allograft survival. Er. J. Ophthalmol. 81, 778-784.
301. Ma, S. W., Zhao, D. L., Yin, Z. Q., Mukherjee, R., Singh, B., Qin, H. Y., Stiller, C. R., and Jevnikar, A. M. (1997b). Transgenic plants expressing autoantigens fed to mice to induce oral immune tolerance. Nature Med. 3, 793-796.
302. Ma, D., Mellon, J., and Niederkorn, J. Y. (1998). Conditions affecting enhanced comeal allograft survival by oral immunization. Invest. Ophthalmol. Vis. Sci. 39, 1835-1846.
303. MacDonald, T. T. (1982). Immunosuppression caused by antigen feeding. I. Evidence for the activation of a feedback suppressor pathway in the spleens of antigen-fed mice. Eur. J. Immunol. 12, 767-773.
304. Macfarlane, G. T., and Macfarlane, S. (1997). Human colonie microbiota: ecology, physiology and metabolic potential of intestinal bacteria. Scand. J. Castroentcrol. (Suppl.) 222, 3-9.
305. Mahida, Y. R., Wu, K. C., and Jewell, D. P. (1988). Characterization of antigen-presenting activity of intestinal mononuclear cells isolated from normal and inflammatory bowel disease colon and ileum. Immunology 65, 543-549.
306. Maia, L. C. S., Vaz, N. M., and Vaz, E. M. (1974). Effect of soluble antigen on IgE responses in the mouse. Int. Arch. Allergy Appl. Immunol. 46, 339-346.
307. Mannie, M. D., Rendall, S. K., Arnold, P. Y., Nardella, J. P., and White, G. A. (1996). Anergy-associated T-cell antigen presentation. J. Immunol. 157, 1062-1070.
308. Maron, R., and Weiner, II. L. (1998). Oral tolerance in neonatal NOD mice to autoantigens: Oral insulin suppresses diabetes but oral myelin oligodendrocyte glycoprotein (MOG) has no effect on experimental autoimmune encephalomyelitis (EAE). Diabetes 47, A210.
309. Maron, R., Melican, N. S., and Weiner, H. L. (1999). Regulatory Th2 type T cell lines against insulin and GAD peptides derived from orally and nasally treated NOD mice suppress diabetes. J. Autoimmun., in press. Maron, R., Palanivel, V., Weiner, H. L., and Ham, D. A. (1998a). Oral administration of insulin B-chain and schistosome egg antigens generate and enhances Th2-type responses in NOD mice. Clin. Immunol. Immunopatnol. 87, 85-92.
310. Maron, R., Slavin, A., and Weiner, H. L. (1998b). Oral tolerance to glatiramer acetate (Copl, Copaxone) in MBPT cell receptor transgenic mice. J. Neuroimmunol. 90, 82.
311. Marth, T., Strober, W., and Kelsall, B. L. (1996). High dose oral tolerance in ovalbumin TCR-transgenic mice: Systemic neutralization of IL-12 augments TGF-β secretion and T-cell apoptosis. J. Immunol. 157, 2348-2357.
312. Matsui, M., Hafier, D. A., and Weiner, H. L. (1996). Pilot study of oral tolerance to keyhole limpet hemocyanin in humans: Down-regulation of KLH-reactive precursor-cell frequency. Ann. N.Y. Acad. Sci. 778, 398-404.
313. Mattingly, J. A., and Waksman, B. H. (1978). Immunologie suppression after oral administration of antigen. I. Specific suppressor cells formed in rat Peyer's patches after oral administration of sheep erythrocytes and their systemic migration.J. Immunol. 121, 1878-1882.
314. Matzinger, P. (1994). Tolerance, danger, and the extended family. Anna. Rev. Immunol. 12, 991-1045.
315. Mayer, L. (1996). Oral tolerance: Boom or bust for autoimmunity. Inflamm. Bowel Dis. 2, 211-213.
316. Mayer, L., and Eisenhardt, D. (1990). Lack of induction of suppressor T-cells by intestinal epithelial cells from patients with inflammatory bowel disease.J. Clin. Incest. 86, 1255-1260.
317. Mayer, L., and Shlien, R. (1987). Evidence for function of la molecules on gut epithelial cells in man. J. Exp. Med. 166, 1471-1483.
318. Mayer, L., So, L. P., Yio, X. Y., and Small, G. (1996). Antigen trafficking in the intestine. Ann. MY. Acad. Sci. 778, 28-35.
319. McKown, K. M., Carbone, L. D., Bustillo, J., Sever, J. M., Kang, A. H., and Postlethwaite, A. E. (1997). Open trial of oral type I collagen in patients with systemic sclerosis. Arthritis Rheum. 40, S100.
320. + Tcr alpha-/beta-lyrriphocytes (putative gamma/delta T-cells). Immunology 74, 234-239.
321. McMenamin, C., Pimm, C., McKersey, M, and Holt, P. G. (1994). Regulation of IgE responses to inhaled antigen in mice by antigen-specific pS T-cells. Science 265, 1869-1871.
322. McMenamin, C., McKersey, M., Kuhnlein, P., Hunig, T., and Holt, P. G. (1995). μδ T-cells down-regulate primary IgE responses in rats to inhaled soluble protein antigens. J. Immunol. 154, 4390-4394.
323. Melamed, D., and Friedman, A. (1993a). Direct evidence for anergy in T lymphocytes tolerized by oral administration of ovalbumin. Eur. J. Immunol. 23, 935-942.
324. Melamed, D., and Friedman, A. (1993b). Modification of the immune response by oral tolerance: Antigen requirements and interaction with immunogenic stimuli. Cell. Immunol 146, 412-420.
325. Melamed, D., and Friedman, A. (1994). In vivo tolerization of Thl lymphocytes following a single feeding with ovalbumin: Anergy in the absence of suppression. Eur. J. Immunol. 24, 1974-1981.
326. Melamed, D., Fishman-Lovell, J Uni, Z., Weiner, H. L., and Friedman, A. (1996). Peripheral tolerance of Th2 lymphocytes induced by continuous feeding of ovalbumin. Int. Immtmol. 8, 717-724.
327. Mengel, J., Cardillo, F., Aroeira, L. S., Williams, O., Russo, M., and Vaz, N. M. (1995). AntiyS T-cell antibody blocks the induction and maintenance of oral tolerance to ovalbumin in mice. Immunol. Lett. 48, 97-102.
328. Mestecky, J. (1987). The common mucosal immune system and current strategies for induction of immune responses in external secretions. J. Clin. Immunol. 7, 265-276.
329. Metzler, B., and Wraith, D. C. (1993). Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: Influence of MHC binding affinity. Int. Immunol. 5, 1159-1165.
330. Meyer, A., Gienapp, I., Cox, K., Goverman, J., Hood, L., and Whitacre, C. (1996a). Oral tolerance in myelin basic protein TCR transgenic mice. Ann. N. V. Acad. Sci. 778,412-413.
331. Meyer, A. L., Benson, J. M., Gienapp, I. E., Cox, K. L., and Whitacre, C. C. (1996b). Suppression of murine chronic relapsing experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein. J. Immunol. 157, 4230-4238.
332. Meyers, L. K.,Brand, D.D.,Ye,X. J.,Cremer,M. A.,Rosloniec,E. F.,Bodo, M.,Myllyharju, J., Helaakoski, T., Nokelainen, M. Pihlajaniemi, T., Kivirikko, K., Yang, C. L., Ala-Kokko, L., Prockop, D. J., Notbohm, H., Fietzek, P., Suart, J. M., and Kang, A. II. (1998). Characterization of recombinant type II collagen: Arthritogenicity and tolerogenicity in DBA/1 mice. Immunology 95, 631-9.
333. Michael, J. (1989). The role of digestive enzymes in orally induced immune tolerance. Immunol. Invest. 18, 1049-1054.
334. Migita, K., and Ochi, A. (1994). Induction of clonal anergy by oral administration of staphylococcal enterotoxin B. Eur. J. Immunol. 24, 2081-2086.
335. Miller, S., and Hanson, D. (1979). Inhibition of specific immune responses by feeding protein antigens. IV. Evidence for tolerance and specific active suppression of cellmediated immune responses to ovalbumin. J. Immunol. 123, 2344-2350.
336. Miller, M. L., Cowdery, J. S., Laskin, C. A., Curtin; M., Jr., and Steinberg, A. D. (1984). Heterogeneity of oral tolerance defects in autoimmune mice. Clin. Immunol. Immunopathol. 31, 231-240.
337. Miller, A., Lider, O., and Weiner, H. L. (1991). Antigen-driven bystander suppression following oral administration of antigens.J. Exp. Med. 174, 791-798.
338. Miller, A., Lider, O., al-Sabbagh, A., and Weiner, H. (1992a). Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. V. Hierarchy of suppression by myelin basic protein from different species. J. Neuroimmunol. 39, 243-250. :'
339. Miller, A., Lider, O., Roberts, A. B., Sporn, M. B., and Weiner, H. L. (1992b). Suppressor T-cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of TGF-β following antigen specific triggering. Proc. Natl. Acad. Sci. U.S.A. 89, 421-425.
340. Miller, A., al-Sabbagh, A., Santos, L., Das, M. P., and Weiner, H. L. (1993a). Epitopes of myelin basic protein that trigger TGF-β release following oral tolerization are distinct from encephalitogenic epitopes and mediate epitope driven bystander suppression. J. Immunol. 151, 7307-7315.
341. Miller, A., Zhang, Z. J., Sobel, R. A., al-Sabbagh, A., and Weiner, ILL. (1993b). Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. VI. Suppression of adoptively transferred disease and differential effects of oral vs. intravenous tolerization. J. Neuroimmunol. 46, 73-82.
342. Miller, A., Lider, O., Abramsky, O., and Weiner, H. L. (1994a). Orally administered myelin basic protein in neonates primes for immune responses and enhances experimental autoimmune encephalomyelitis in adult animals. Eur. J. Immunol. 24, 1026-1032.
343. Miller, B. G., Whittemore, C. T., Stokes, C. R., and Telemo, E. (1994b). The effects of delayed weaning on the development of oral tolerance to soya-bean protein in pigs. Br. J. Nutr. 71, 615-625.
344. Miossec, P., and van den Berg, W. (1997). Th1/Th2 cytoldne balance in arthritis [see comments]. Arthritis Wieiim. 40, 2105-2115.
345. Moalem, G., Leibowitz-Amit, R., Yoles, E., Mor, F., Cohen, I. R., and Schwartz, M. (1999). Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat. Med. 5(1), 49-55.
346. Moog, F. (1981). The lining of the small intestine. Sci. Am. 245, 116-125.
347. Mordes, J. P., Schirf, B., Roipko, D., Grenier, D. L., Weiner, H. L., Nelson, P., and Rossini, A. A. (1996). Oral insulin does not prevent insulin-dependent diabetes mellitus in BB rats. Ann. N.V. Acad. Sci. 778, 418-421.
348. Moreau, M. C., and Corthier, G. (1988). Effect of the gastrointestinal microflora on induction and maintenance of oral tolerance to ovalbumin in C3H/HeJ mice. Infect. Immun. 56, 2766-2768.
349. Moreau, M. C., and Gaboriau-Routhiau, V. (1996). The absence of gut flora, the doses of antigen ingested and aging affect the long-term peripheral tolerance induced by ovalbumin feeding in mice. Res. Immunol. 147, 49-59.
350. Morris, D. L. (1998). Intradermal testing and sublingual desensitization for nickel. Cutis 61, 129-132.
351. Mowat, A. M. (1986). Depletion of suppressor T-cells by 2'-deoxyguanosine abrogates tolerance in mice fed ovalbumin and permits the induction of intestinal delayed-type hypersensitivity. Immunology 58, 179-184.
352. Mowat, A. M. (1987). The regulation of immune responses to dietary protein antigens. Immunol Today 8, 93-98.
353. Mowat, A. M. (1994). Oral tolerance and regulation of immunity to dietary antigens. In "Handbook of Mucosal Immunology" (P. L. Ogra, M. E. Lamm, J. R. McGhee, J. Mestecky, W. Strobe., and J. Bienensta eds.), Vol. 16, pp. 185-201. Academic Press, San Diego.
354. Mowat, A. (1998). Putative role of p55 TNF receptor, but not fas in oral tolerance. FASEB J. 12, A598.
355. Mowat, A., and Ferguson, A. (1982). Migration inhibition oflymph nodes lymphocytes as an assay for regional cell-mediated immunity in the intestinal lymphoid tissues of mice immunized orally with ovalbumin. Immunology 47, 365-370.
356. Mowat, A. M., and Parrot, D. M. (1983). Immunological responses to fed protein antigens in mice. IV. Effects of stimulating the reticuloendothelial system on oral tolerance and intestinal immunity to ovalbumin. Immunology 50, 547-554.
357. Mowat, A. M., Strobel, S., Drummond, H. E., and Ferguson, A. (1982). Immunological response to fed protein antigens in mice: I. Reversal of oral tolerance to ovalbumin by cyclophosphamide. Immunology 45, 105-113.
358. Mowat, A. M., Thomas, M. J., MacKenzie, S., and Parrott, D. M. (1986). Divergent effects of bacterial lipopolysaccharide on immunity to orally administered protein and particulate antigens in mice. Immunology 58, 677-683.
359. Mowat, A. M., Steel, M., Worthy, E. A., Kewin, P. J., and Garside, P. (1996). Inactivation of Till and Th2 cells by feeding ovalbumin. Ann. iV.Y. Acad. Sci. 778, 122-132.
360. Muckerheide, A., Apple, R. J., Pesce, A. J., and Michael, J. G. (1987). Cationization of protein antigens II. Alteration of regulatory properties. J. Immunol. 138, 833-837.
361. Mueller, D. L., Jenkins, M. K., and Schwartz, R. H. (1989). Clonal expansion versus functional clonal inactivation: A costimulatory signalling pathway determines the outcome of T-cell antigen receptor occupancy. Annu. Rev. Immnnol. 7, 445-480.
362. Muller, C. P. (1994). Mucosal vaccines: High-tech reagents for low-tech immunization. Immnnol. Today 15, 458-459.
363. Myers, L. K., Seyer, J. M., Stuart, J. M., and Kang, A. H. (1997). Suppression of murine collagen-induced arthritis by nasal administration of collagen. Immunology 90, 161-164.
364. Myers, L. K., Brand, D. D., Ye, X. J., Cremer, M. A., Rosloniec, E. F., Bodo, M., Myllyharju, J., Helaakoski, T., Nokelainen, M., Pihlajaniemi, T., Kivirikko, K., Yang, C. L., Ala-Kokko, L., Prockop, D. J., Notbohm, II., Fietzek, P., Stuart, J. M., and Kang, A. H. (1998). Characterization of recombinant type II collagen: Arthritogenicity and tolerogenicity in DBA/1 mice. Immunology 95, 631-639.
365. Nagler-Anderson, C., Bober, L. A., Robinson, M. E., Siskind, G. W., and Thorbeke, F. J. (1986). Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc. Natl. Acad. Sci. U.S.A. 83, 7443-7446.
366. Nakao, A., Kasai, M., Kumano, K., Nakajima, IL, Kurasawa, K., and Iwamoto, I. (1998). High-dose oral tolerance prevents antigen-induced eosinophil recruitment into the mouse airways. Int. Immunol 10, 387-394.
367. Nelson, P. A., Akselband, Y., Dearborn, S., al-Sabbagh, A., Tian, Z. J., Gonnella, P., Zamvil, S., Chen, Y., and Weiner, H. L. (1996). Effect of oral beta interferon on subsequent immune responsiveness. Ann. N.Y. Acad. Sci. 778, 145-155.
368. Neurath, M. F., Fuss, I., Kelsall, B. L., Presky, D. H., Waegell, W., and Strober, W. (1996). Experimental granulomatous colitis in mice is abrogated by induction of TGF-β-mediated oral tolerance. J. Exp. Med. 183, 2605-2616.
369. Neutra, R. M., and Kraehenbuhl, J.-P. (1996). M cells as a pathway for antigen uptake and processing. In "Essentials of Mucosal Immunology" (M. F. Kagnoff and H. Kiyono, eds.). Academic Press, San Diego.
370. Neutra, M. R., Frey, A., and Kraehenbuhl, J. P. (1996). Epithelial M cells: Gateways for mucosal infection and immunization. Cell 86, 345-348.
371. Newby, T. J., Stokes, C. R., and Bourne, F. J. (1980). Effects of feeding bacterial lipopolysaccharide and dextran sulphate on the development of oral tolerance to contact sensitizing agents. Immunology 41, 617-621.
372. Ngan, J., and Kind, L. S. (1978). Suppressor T-cells for IgE and IgG in Peyer's patches of mice made tolerant by the oral administration of ovalbumin. J. Immunol. 120, 861-865.
373. Nussenblatt, R. B., Caspi, R. R., Mahdi, R., Chan, C. C., Roberge, F., Lider, O., and Weiner, H. L. (1990). Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen.:J. Immunol. 144, 1689-1695.
374. Nussenblatt, R. B., Gery, L, Weiner, II. L., Ferns, F., Shiloach, J., Ramaley, N., Perry, C., Caspi, R., Hafler, D. A., Foster, S., and Whitcup, S. M. (1997). Treatment of uveitis by oral administration of retinal antigens: Results of a phase I/II randomized masked trial. Am. J. Ophthalmol. 123, 583-592.
375. Oettinger, H. F., al-Sabbagh, A., Jingwu, Z., LaSalle, J. M., Weiner, II. L., and Hafler, D. A. (1993). Biological activity of recombinant human myelin basic protein.J. Neuroimmunol. 44, 157-162.
376. Ogra, P. (1980). Ontogeny of the local immune system. Pediatrics 64, 675-687.
377. Okumura, S., Mclntosh, K., and Drachman, D. B. (1994). Oral administration of acetylcholine receptor: Effects on experimental myasthenia gravis. Ann. Neural. 36, 704-713.
378. Oliver, A. R., and Silbart, L. K. (1998). Local and systemic tolerance to orally administered dinitrochlorobenzene is not broken by cholera toxin. Int. Arch. Allergy Immunol. 116, 318-324.
379. Oliver, A. R., Silbart, L. K., Keren, D. F., Van Kruiningen, II. J., Miller, B. F., and Rearick, C. (1997). Mucosal unresponsiveness to aflatoxin B1 is not broken by cholera toxin. Immiinol. Cell Biol. 75, 47-53.
380. O'Mahony, S., Arranz, E., Barton, J. R., and Ferguson, A. (1991). Dissociation between systemic and mucosal humoral immune responses in cocliac disease. Cut 32, 29-35.
381. Panja, A., andMayer, L. (1994). Diversity and function of antigen-presenting cells in mucosal tissues. In "Handbook of Mucosal Immunology" P. L. Ogra, M. E. Lamm, J. R. McGhee, J. Mestecky, W. Strober, and J. Bienenstock, eds., Vol. 16, pp. 177-181. Academic Press, San Diego.
382. Panja, A., Blumberg, R. S., Balk, S. P., and Mayer, L. (1993). CDld is involved in Tcell-intestinal epithelial cell interactions. J. Exp. Med. 178, 1115-1119.
383. Panja, A., Barone, A., and Mayer, L. (1994). Stimulation oflamina propria lymphocytes by intestinal epithelial cells: Evidence for recognition of nonclassical restriction elements. J. Exp. Med. 179, 943-950.
384. Peng, H. J., Turner, M. W., and Strobel, S. (1989). Failure to induce oral tolerance to protein antigens in neonatal mice can be corrected by transfer of adult spleen cells. Pediatr. Res. 26, 486-490.
385. Peng, H.J..Turner, M. W., and Strobel, S. (1990). The generation of a "tolerogen" after the ingestion of ovalbumin is time-dependent and unrelated to serum levels of immunoreactive antigen. Clin. Exp. Immunol. 81, 510-515.
386. Peng, H. J., Chang, Z. N., Han, S. II., Won, M. IL, and Huang, B. T. (1995). Chemical denaturation of ovalbumin abrogates the induction of oral tolerance of specific IgG antibody and DTH responses in mice. Scancl. J. Immiinol. 42, 297-304.
387. Peng, H. J., Chang, Z. N., Lin, S. Y., Han, S. IL, and Chang, C. H. (1998a). Chemical denaturation of ovalbumin abrogates the induction of oral tolerance of mouse reaginic antibody responses. Scancl. J. Immunol. 47, 475-480.
388. Peng, H. J., Chang, Z. N., Tsai, L. C., Su, S. N., Shen, H. D., and Chang, C. H. (1998b). Heat denaturation of egg-white proteins abrogates the induction of oral tolerance of specific Th2 immune responses in mice. Scand. J. Immunol. 48, 491-496.
389. Peri, B. A., Theodore, C. M., Losonsky, G. A., Fishaut, J. M., Rothberg, R. M., and Ogra, P. L. (1982). Antibody content of rabbit milk and serum following inhalation or ingestion of respirator}' syncytial virus and bovine serum albumin. Clin. Exp. Immunol. 48,91-97.
390. Peterson, K. E., and Braley-Mullen, H. (1995). Suppression of murine experimental autoimmune thyroiditis by oral administration of porcine thyroglobulin. Cell. Immiinol. 16G, 123-130.
391. Ploix, C., Bergerot, L, Fabien, N., Moulin, V., and Thivolet, C. (1998). Protection against autoimmune diabetes with oral insulin is associated with the homing of IL-4 T helper type 2 cells to the pancreas and pancreatic lymph nodes. Diabetes 47, 39-44.
392. Polanski, M., Blogg, N. S., Zhang, J., and Weiner, IL L. (1997). Oral administration of the immunodominant B-chain of insulin suppresses diabetes in NOD mice and is associated with a switch from Thl to Th2 cytokines. J. Atitoimmun. 10, 339-346.
393. Popovich, P. G., Yu, J. Y., and Whitacre, C. C. (1997). Spinal cord neuropathology in rat experimental autoimmune encephalomyelitis: Modulation by oral administration of myelin basic protein.J. Neuropathol. Exp. Neural. 56, 1323-1338.
394. + T-cells are important for the balance between protective and pathogenic cell-mediated immunity. J. Exp. Med. 179, 589-600.
395. Powrie, F., Carlino, J., Leach, M. W., Mauze, S., and Coffman, R. L. (1996). A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB (low) CD4+ T-cells.J. Exp. Med. 183, 2669-2674.
396. Prakken, B. J., van der Zee, R., Anclerton, S. M., van Kooten, P. J. S., Kuis, W., and van Eden W. (1997). Peptide-induced nasal tolerance for a mycobacterial heat shock protein 60 T-cell epitope in rats suppresses both adjuvant arthritis and nonmicrobially induced experimental arthritis. Proc. Natl. Acacl. Sci. U.S.A. 94, 3284-3289.
397. Pullerits, T., Lundin, S., Gui, Z. IL, Dahlgren, U., Telemo, E., and Lotvall, J. (1998). Bystander suppression of occupational hapten sensitization in rats made tolerant to ovalbumin. Eur. Respir. J. 12, 889-894.
398. Qian, J., Hashimoto, T., Fujiwara, H., and Hamaoka, T. (1985). Studies on the induction of tolerance to alloantigens. I. The abrogation of potentials for delayed-type-hypersensitivity response to alloantigens by portal venous inoculation with allogeneic cells. J. Immunol. 134, 3656-3661.
399. Qin, S., Cobbold, S. P., Pope, IL, Elliott, J., Kioussis, D., Davies, J., and Waldmann, II. (1993). 'Infectious' transplantation tolerance. Science 259, 974-977.
400. Quinti, I., Paganelli, R., Scala, E., Guerra, E., and Aiuti, F. (1989). Humoral response to food antigens. Allergy 44, 59-64.
401. Racke, M. K., and Lovett-Racke, A. E. (1998). Bystander suppression in experimental autoimmune encephalomyelitis: Where and how does it occur? Res. Imnmnol. 149, 820-827.
402. Reese, R. T., and Cebra, J. J. (1975). Anti-dinitrophenyl antibody production in strain 13 guinea pigs fed or sensitized with dinitrochlorobenzene. J. Imnmnol. 114, S63-871.
403. Renz, IL, Bradley, K., Saloga, J., Loader, J., Larsen, G. L., and Gelfand, E. W. (1993). T-cells expressing specific V beta elements regulate immunoglobulin E production and airways responsiveness in vivo. J. Exp. Mecl. 177, 1175-1180.
404. Renz, IL, Lack, G., Saloga, J., Schwinzer, R., Bradley, K., Loader, J., Kupfer, A., Larsen, G. L., and Gelfand, E. W. (1994). Inhibition of IgE production and normalization of airways responsiveness by sensitized CDS T-cells in a mouse model of allergen-induced sensitization. J. Immunol. 152, 351-360.
405. Richman, L. K., Chiller, J. M., Broun, W. R., Hanson, D. G., and Vaz, N. M. (1978). Enterically induced immunological tolerance. I. Induction of suppressor T lymphocytes by intragastric administration of soluble proteins.J. Immunol. 121, 2429-2433.
406. Richman, L. K., Graeff, A. S., and Strober, W. (1981a). Antigen presentation by macrophageenriched cells from the mouse Peyer's patch. Cell. Immunol. 62, 110-118.
407. Richman, L. K., Graeff, A. S., Yarchoan, R., and Strober, W. (1981b). Simultaneous induction of antigen-specific IgA helper T-cells and IgA suppressor T-cells in the murine Peyer's patch after protein feeding. J. Immnnol. 126, 2079-2083.
408. Rios, M. J. C., Pereira, M. A. C., Lopes, L. M., Faria, A. M. C., Gontijo, C. M., Castanheira, E. B., and Vaz, N. M. (1988). Tolerance.induction and immunological priming initiated by mucosal contacts with protein antigens in inbred strains of mice. Bra;. J. Med. Biol. Res. 21, 825-831.
409. Rizzo, L. V., Morawetz, R. A., Miller-Rivero, N. E., Choi, R., Wiggert, B., Chan, C. C., Morse, II. C., Ill, Nussenblatt, R. B., and Caspi, R. R. (1999). IL-4 and IL-10 are both required for the induction of oral tolerance. J. Immunol. 162(5), 2613-2622.
410. Rizzo, L. V., Miller-Rivero, N. E., Chan, C.-C., Wiggert, B., Nussenblatt, R. B., and Caspi, R. R. (1994). InterIeukin-2 treatment potentiates induction of oral tolerance in a murine model of autoimmunity. J. Clin. Incest. 94, 1668-1672.
411. Rock, K. L., Benacerraf, B., and Abbas, A. K. (1984). Antigen presentation by haptenspecific B-lymphocytes. I. Role of surface immunoglobulin receptors. J. Exp. Med. 160, 1120-1113.
412. + cell subsets. J. Exp. Med. 178, 1637-1644.
413. Rubin, D., Weiner, H., Fields, B., and Greene, M. (1981). Immunologie tolerance after oral administration of reovirus: Requirement for two viral gene products for tolerance induction. J. Immunol. 127, 1697-1701.
414. + T cell tolerance.J. Immunol. 161, 721-728.
415. Russo, M., Jancar, S., Siqueria, A. L. P., Mengel, J., Gomes, E., Ficker, S. M., and Faria, A. M. C. (1998). Prevention of lung eosinophilic inflammation by oral tolerance. Immunol. Lett. 61, 15-23.
416. Sai, P., and Rivereau, A. S. (1996). Prevention of diabetes in the nonobese diabetic mouse by oral immunological treatments. Comparative efficiency of human insulin and two bacterial antigens, lipopolysacharide from Escherichia coli and glycoprotein extract from Klebsiella pneumoniae. Diabetes Metab. 22, 341-348.
417. Saito, IL, Kanamori, Y., Takemori, T., Nariuchi, II., Kubota, E., Takahashi-Iwanaga, IL, Iwanaga, T., and Ishikawa, H. (1998). Generation of intestinal T-cells from progenitors residing in gut cryptopatches. Science 280, 275-278.
418. Saklayen, M. G., Pesce, A. J., Pollak, V. E., and Michael, J. G. (1983). Induction of oral tolerance in mice unresponsive to bacterial lipopolysaccharide. Infect. Immun. 41,13831385.
419. Saklayen, M. G., Pesce, A. J., Pollak, V. E., and Michael, J. G. (1984). Kinetics of oral tolerance: study of variables affecting tolerance induced by oral administration of antigen. Inf. Arch. Allergy Appl. Immunol. 73, 5-9.
420. Salom, R. N., Maguire, J. A., and Hancock, W. W. (1992). Mechanism of a clinically relevant protocol to induce tolerance: Peritransplant spleen cells plus cyclosporine suppress IL2 and IFN-gamma production. Transplant. Proc. 24, 2307-2308.
421. Samoilova, E. B., Horton, J. L., Zhang, H., Khoury, S. J., Weiner, H. L., and Chen, Y. (1998). CTLA4 is required for the induction of high dose oral tolerance. Int. Immunol. 10, 491-498.
422. Sampson, IL A., and Metcalfe, D. D. (1992). Food allergies. JAMA 268, 2840-2844.
423. Sanderson, I. R., and Walker, W. A. (1993). Uptake and transport of macromolecules by the intestine: Possible role in clinical disorders (an update). Gastroenterologij 104, 622-639.
424. Santos, L. M. B., al-Sabbagh, A., Londono, A., and Weiner, H. L. (1994). Oral tolerance to myelin basic protein induces regulatory TGF-β-secreting T-cells in Peyer's patches of SJL mice. Cell. Immunol 157, 439-447.
425. Sato, S., Qian, J. H., Kokudo, S., Ikegami, R., Suda, T., Hamaoka, T., and Fujiwara, II. (1988). Studies on the induction of tolerance to alloantigens. III. Induction of antibodies directed against alloantigen-specific delayed-type hypersensitivity T-cells by a single injection of allogeneic lymphocytes via portal venous route. J. Immunol. 140, 717-722.
426. Sato, M. N., Can-alho, A. F., Suva, A. O., Maclel, Jr., M., Fusaro, A. E., and Duarte, A. J. (1998). Oral tolerance induced to house dust mite extract in naive and sensitized mice: Evaluation of immunoglobulin G, anti-immunoglobulin G, anti-immunoglobulin E autoantibodies and IgC-IgE complexes. Immunology 95, 193-199.
427. Sayegh, M. H., Khoury, S. J., Hancock, W. H., Weiner, IL L., and Carpenter, C. B. (1992a). Induction of immunity and oral tolerance with polymorphic class II major histocompatability complex allopeptides in the rat. Proc. Natl. Acacl. Sci. U.S.A. 89, 7762-7766.
428. Sayegh, M. H., Zhang, Z. J., Hancock, W. W., Kwok, C. A., Carpenter, C. B., and Weiner, II. L. (1992b). Down-regulation of the immune response to histocompatibility antigen and prevention of sensitization by skin allografts by orally administered alloantigen. Transplantion 53, 163-166.
429. Scadding, G. K., and Brostoff, J. (1986). Low dose sublingual therapy in patients with allergic rhinitis due to house dust mite. Clin. Allergy 16, 483-491.
430. Schalkwijk, J., van den Berg, W. B., van de Putte, L. B. A., Joosten, L. A. B., and van den Bersselaar, L. (1985). Cationization of catalase, peroxidase, and Superoxide dismutase. Effect of improved intraarticular retention on experimental arthritis in mice. J. Clin. Invest. 76, 198-205.
431. Schwartz, R. H. (1990). A cell culture model for T lymphocyte clonal anergy. Science 248, 1349-1356.
432. Schwartz, R. IL, Mueller, D. L., Jenkins, M. K., and Quill, H. (1989). T-cell clonal anergy. Cold Spring Harb. Symp. Quant. Biol. 54, 605-610.
433. Seddon, B., and Mason, D. (1999). Regulatory T cells in the control of autoimmunity: The essential role of transforming growth factor beta and interleukin 4 in the prevention of autoimmune thyroiditis in rats by peripheral CD4(+)CD45RC- cells and CD4(+)CD8(-) thymocytes. J. Exp. Med. 189, 279-288.
434. Seder, R. A., Marth, T., Sieve, M. C., Strober, W., Letterio, J. J., Roberts, A. B., and Kelsall, B. (1998). Factors involved in the differentiation of TGF-/3-producing cells from naive CD4 T-cells: IL-4 and IFN-y have opposing effects, while TGF-/3 positively regulates its own production. J. Immunol. 160, 5719-5728.
435. Sedgwick, J. D., and Holt, P. G. (1983). Induction of IgE-isotype specific tolerance by passive antigenic stimulation of the respiratory mucosa. Immunology 50, 625-630.
436. Sedgwick, J. D., and Holt, P. G. (1985). Down-regulation of immune responses to inhaled antigen: Studies on the mechanism of induced suppression. Immunology 56, 635-642.
437. Sellon, R. K., Tonkonogy, S. L., Grable, H., Kwon, J., Schultz, M., Balish, E., Rennick, D., and Sartor, R. B. (1997). Development of spontaneous colitis in IL-10 knockout mice requires normal enteric bacterial flora. Gastroenterology 112, A1088.
438. Sercarz, E., and Krzych, U. (1991). The distinctive specificity of antigen-specific suppressor T-cells. Immunol. Today 12, 111-118.
439. + T-cells or interferon (IFN)-gamma in a murine model of allergen sensitization.J. Exp. Med. 187, 721-731.
440. Shenker, B. J., Listgarten, M. A., and Taichman, N. S. (1984). Suppression of human lymphocyte responses by oral spirochetes: A monocyte-dependent phenomenon.J. Immunol 132, 2039-2045.
441. Shi, F. D., Bai, X. F., Xiao, B. G., van der Meide, P. H., and Link, H. (1998). Nasal administration of multiple antigens suppresses experimental autoimmune myasthenia gravis, encephalomyelitis and neuritis.J. Neural. Sci. 155, 1-12.
442. Sicinki, P. J., Rowinski, J. B., Warchol, A., Jarzabek, Z., Gut, W., Szcygiel, B., Bielecki, K., and Koch, G. (1990). Poliovirus type I enters the human host through intestinal M cells. Gastroenterology 98, 56-58.
443. Sieper, J., Kary, S., Sörensen, IL, Alten, R., Eggens, U., Huge, W., Hiepe, F., Kühne, A., Listing, J., Ulbrich, N., Braun, J., Zink, A., and Mitchison, N. A. (1996). Oral type II collagen treatment in early rheumatoid arthritis. Arthritis RJieum. 39, 41-51.
444. Singer, G., and Abbas, A. (1994). The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T-cell receptor transgenic mice. Immunity 1, 365-371.
445. Singh, V. K., Kalra, H. K., Yamaki, K., and Shinohara, T. (1992). Suppression of experimental autoimmune uveitis in rats by the oral administration of the uveitopathogenic S-antigen fragment and a cross-reactive homologous peptide. Cell. Immunol. 139, 81-90.
446. Singh, V. K., Anand, R., Sharma, K., and Aganval, S. S. (1996). Suppression of experimental autoimmune uveitis in Lewis rats by oral administration of recombinant Escherichia coli expressing retinal S-antigen. Cell. Immunol. 172, 158-162.
447. Slavin, A. J., Maron, R., Garcia, G., Gonnella, P., and Weiner, H. L. (1998). Oral administration of IL-4 and IL-10 enhance the induction of low dose oral tolerance. FASEBJ. II, A599.
448. Sloan-Lancaster, J., Evavold, B. D., and Alien, P. M. (1993). Induction of T-cell anergy by altered T-cell receptor ligand on live antigen presenting cells. Nature (London) 363, 156-159.
449. Sloan-Lancaster, J., Evavold, B. D., and Alien, P. M. (1994). Th2 cell clonal anergy as a consequence of partial activation.J. Exp. Med. 180, 1195-1199.
450. Sminia, T., and Jeurissen, S. H. (1986). The macrophage population of the gastrointestinal tract of the rat. Immunobiology 172, 72-80.
451. Soos, J. M., Johnson, H. M., Weiner, H. L., and Zamvill, S. S. (1999). Combination therapy with oral IFN-tau and oral myelin basic protein results in increased IL-4 and IL-10 production and enhanced suppression of experimental allergic encephalomyelitis. FASEB J. 13(4), A607.
452. Spahn, T. W., and Weiner, H. L. (1998). yS T-cells are necessary for low dose but not high dose oral tolerance. FASEB J. 12, A597, 3464.
453. Spahn, T. W., Slavin, A. J., Zhang, X., Marino, M. W., Old, L., Fontana, A., and Weiner, H. L. (1999). Evidence for a critical role of the gut associated lymphatic system in the induction of oral tolerance. FASEB J. 13(4), A607.
454. Spalding, D. M., Koopman, W. J., Eldridge, J. H., McGhee, J. R., and Steinman, R. (1983). Accessor)' cells in murine Peyer's patch. I. Identification and enrichment of a functional dendritic cell. J. Exp. Med. 157, 1646-1659.
455. Spalding, D. M., Williamson, S. I., Koopman, W. J., and McGhee, J. R. (1984). Preferential induction of polyclonal IgA secretion by murine Peyer's patch dendritic cell-T-cell mixtures. J. Exp. Med. 160, 941-946.
456. Spiekermann, G. M., and Nagler-Anderson, C. (1998). Oral administration of the bacterial superantigen staphylococcal enteroto.xin B induces activation and cytokine production by T-cells in murine gut-associated lymphoid tissue. ]. Immiinol. 161, 5825-5831.
457. Staines, N. A., Harper, N., Ward, F. J., Malmström, V., Holmdahl, R., and Bansal, S. (1996). Mucosal tolerance and suppression of collagen-induced arthritis (CIA) induced by nasal inhalation of synthetic peptide 184-198 of bovine type II collagen (CII) expressing a dominant T-cell epitope. Clin. Exp. Immiinol. 103, 368-375.
458. Staples, P. J., and Talal, N. (1969). Relative inability to induce tolerance in adult NZB and (NZB X NZW)F1 mice. J. Exp. Med. 130, 123-130.
459. Stavnezer, J., Abbot, J., and Sirlin, S. (1984). Immunoglobulin heavy chain switching in cultured 1.29 murine B cell lymphoma cells: commitment to an IgA or IgE switch. Ciirr. Top. Microbiol. Immiinol. 113, 109-116.
460. Steeber, D. A., Tang, M. L., Zhang, X. Q., Muller, W., Wagner, N., and Tedder, T. F. (1998). Efficient lymphocyte migration across high ehdothelial venules of mouse Peyer's patches requires overlapping expression of L-selectin and beta? integrin. J. Immiinol. 161, 6638-6647.
461. Stokes, R., Newby, T. J., Huntley, J. H., Patel, D., and Bourne, F. J. (1979). The immune response of mice to bacterial antigens given by mouth. Immunology 38, 497-502.
462. Stransky, B., Faria, A. M. C., and Vaz, N. M. (1998). Oral tolerance induction with altered forms of ovalbumin. Braz. J. Med. Biomed. Res. 31, 381-386.
463. Streilein, J., Bradley, D., Eichom, M., Homeber, M., and Lutjen-Drecoll, E. (1993). Evidence that the anterior chamber of primate eyes is immune privileged. Incest. Ophtlialmol. Vis. Sci. 34(Suppl.), 902.
464. Strobel, S. (1996). Neonatal oral tolerance. Ann. N. Y. Acad. Sci. 778, 88-102.
465. Strobel, S., and Ferguson, A. (1984). Immune responses to fed protein antigens in mice. 3. Systemic tolerance or priming is related to age at which antigen is first encountered. Pediatr. Res. 18, 588-594.
466. Strobel, S., and Ferguson, A. (1987). Persistence of oral tolerance in mice fed ovalbumin is different for humoral and cell-mediated immune responses. Immunology 60,317-318.
467. Strobel, S., Mowat, A. M., Drummond, H. E., and Ferguson, A. (1981). Age at first feed influences the immune responses to fed antigens in mice. Pediatr. Res. 15, 1193-1199.
468. Strobel, S., Mowat, A. M., Drummond, H. E., Pickering, M. G., and Ferguson, A. (1983). Immunological responses to fed protein antigens in mice. II. Oral tolerance for CMI is due to activation of cyclophosphamide-sensitive cells by gut-processed antigen. Immunology 49, 451-456.
469. Strobel, S., Mowat, A. M., and Ferguson, A. (1985). Prevention of oral tolerance induction to ovalbumin and enhanced antigen presentation during a graft-versus-host reaction in mice. Immunology 56, 57-64.
470. Strober, W., and Ehrhardt, R. O. (1994) Regulation of IgA B cell development. In "Handbook of Mucosal Immunology" (P. L. Ogra, J. Mestecky, M. E. Lamm, W. Strober, J. R. McGhee, and J. Bienenstock, eds.), Vol. 16, pp. 159-176. Academic Press, San Diego.
471. Suh, E. D., Vistica, B. P., Chan, C.-C., Raber, J. M., Gery, I., and Nussenblatt, R. B. (1993). Splenectomy abrogates the induction of oral tolerance in experimental. Curr. Eye Res. 12, 833-839.
472. Suko, M., Mori, A., Ito, K., and Okudaira, H. (1995). Oral immunotherapy may induce T-cell anergy. Int. Arch. Allergy Immunol. 107, 278-281.
473. Sun, J.-B., Holmgren, C., and Czerkinsky, C. (1994). Cholera toxin B subunit: An efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proc. Nail. Acad. Sci. U.S.A. 91, 10795-10799.
474. Suri-Payer, E., Amar, A. Z., Thornton, A. M., and Shevach, E. M. (1998). CD4+CD25+ Tcells inhibit both the induction and effector function of autoreactive T-cells and represent a unique lineage of immunoregulatory cells.J. Iinmtinol. 160, 1212-1218.
475. Swarbrick, E. T., Stokes, C. R., and Soothill, J. F. (1979). Absorption of antigens after oral immunization and the simultaneous induction of specific systemic tolerance. Gut 20, 121-125.
476. Swierkiosz, J. E., and Swanborg, R. II. (1977). Immunoregulation of experimental allergic encephalomyelitis: Conditions for induction of suppressor cells and analysis of mechanism. J. Immunol. 119, 1501-1506.
477. Taams, L. S., van Rensen, A. J. M. L., Poelen, M. C. M., van Els, C. A. C. M., Besseling, A. C., Wagenaar, J. P. A., van Eden, W., and Wauben, M. H. M. (1998). Anergic T-cells actively suppress T-cell responses via the antigen-presenting cell. Eur. J. Immunol. 28, 2902-2912.
478. Tada, Y., Ho, A., Koh, D. R., and Mak, T. W. (1996). Collagen-induced arthritis in CD4or CDS-deficient mice. CDS~ T-cells play a role in initiation and regulate recovery phase of collagen-induced arthritis.J. Immunol.:15G, 4520-4526.
479. Takeuchi, M., Kosiewicz, M. M., Alard, P., and Streilein, J. W. (1997). On the mechanisms by which transforming growth factor-beta 2 alters antigen-presenting abilities of macrophages on T-cell activation. Eur. ]. Immunol. 27, 1648-1656.
480. Takeuchi, M., Alard, P., and Streilein, J. W. (1998). TGF-/3 promotes immune deviation by altering accessory signals of antigen-presenting cells. J. Immunol. 160, 1589-1597.
481. Taudorf, E. (1992). Oral immunotherapy of adults with allergic rhinoconjunctivitis: Clinical effects in birch and grass pollinosis. Dan. Med. Bull. 39, 542-560.
482. Taudorf, E., Laursen, L. C., Lanner, A., Bjorksten, B., Dreborg, S., Seborg, M., and Weeke, B. (1987). Oral immunotherapy in birch pollen hay fever. J. Allergy Clin. Immunol. 80, 153-161.
483. Teitelbaum, D., Arnon, R., and Sela, M. (1998). Immunomodulation of experimental allergic encephalomyelitis by oral administration of copolymer 1 (Copaxone®).J. Neuroimmunol. 90, 85.
484. Teitelbaum, D., Amon, R., and Sela, M. (1999). Iminunomodulation of experimental autoimmune encephalomyelitis by oral administration of copolymer 1. Proc. Natl. Acad. Sci. U.S.A. 96, 3842-3847.
485. Teng, Y., Gorczynski, R., and Hozumi, N. (1998). The function of TGF-beta-mediated innocent bystander suppression associated with physiological self-tolerance in vivo. Cell. Imimmol. 190, 51-60.
486. Terato, K., Xiu, J. Y., Miyahara, H., Cremer, M. A., and Griffiths, M. M. (1996). Induction by chronic autoimmune arthritis in DBA/1 mice by oral administration of type II collagen and Escherichia coJi lipopolysaccharide. Br. J. Rlietnnatol. 35, 828-838.
487. Thomas, H. C., and Parrott, D. M. V. (1974). The induction of tolerance to a soluble protein antigen by oral administration. Immunology 27, 631-639.
488. Thomas, H. C., Ryan, C. J., Benjamin, I. S., Blumgart, L. H., and MacSween, R. N. M. (1976). The immune system response in cirrhotic rats. The induction of tolerance to orally administered protein antigens. Gastroenterology 71, 114-117.
489. Thompson, II. S., and Staines, N. A. (1986a). Suppression of collagen-induced arthritis with pregastrically or intravenously administered type II collagen. Agents Actions 19,318-319.
490. Thompson, H. S. G., and Staines, N. A. (1986b). Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats. Clin. Exp. Immunol. 64, 581-586.
491. Thompson, II. S. and Staines, N. A. (1990). Could specific oral tolerance be a therapy for autoimmune disease? Immunol. Today 11, 396-399.
492. Thompson, H. S. G., Harper, N., Bevan, D. J., and Staines, N. A. (1993a). Suppression of collagen induced arthritis by oral administration of type II collagen: Changes in immune and arthritic responses mediated by active peripheral suppression. Atitoimmunity 16, 189-199.
493. Thompson, S. J., Thompson, H. S. G., Harper, N., Day, M. J., Coad, A. J., Elson, C. J., and Staines, N. A. (1993b). Prevention of pristane-induced arthritis by the oral administration of type II collagen. Immunology 79, 152-157.
494. Thorbecke, G. J., Schwarcz, R., Leu, J., Huang, C., and Simmons, W. J. (1999). Modulation by cytokines of induction of oral tolerance to type II collagen. Arthritis RJieum. 42,110-118.
495. Thurau, S. R., Chan, C. C., Suh, E., and Nussenblatt, R. B. (1991). Induction of oral tolerance to S-antigen induced experimental autoimmune uveitis by a uveitogenic 20mer peptide.J. Autoimmtin. 4, 507-516.
496. Thurau, S. R., Chan, C. C., Nussenblatt, R. B., and Caspi, R. R. (1997a). Oral tolerance in a murine model of relapsing experimental autoimmune uveoretinitis (EAU): Induction of protective tolerance in primed animals. Clin. Exp. Immunol. 109, 370-376.
497. Thurau, S. R., Diedrichs-Mohring, M., Fricke, H., Arbogast, S., and Wildner, G. (1997b). Molecular mimicry as a therapeutic approach for an autoimmune disease: Oral treatment of uveitis-patients with an MHC-peptide crossreactive with autoantigen-first results. Immunol. Lett. 57, 193-201.
498. Tian, J., Atkinson, M. A., Clare-Salzler, M., Herschenfeld, A., Forsthuber, T., Lehmann, P. V., and Kaufman, D. L. (1996). Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J. Exp. Med. 183, 1561-1567.
499. Titus, R. G., and Chiller, J. M. (1981). Orally induced tolerance. Definition at the cellular level. Int. Arch. Allergy Appl. Immunol. 65, 323-338.
500. Torseth, J. W., and Gregerson, D. S. (1998). Oral tolerance in experimental autoimmune uveoretinitis: Feeding after disease induction is less protective than prefeeding. C//i. Immunol. Immunopathol. 88, 297-304.
501. Trentham, D. E., Townes, A. S., and Kang, A. S. (1977). Autoimmunity to type II collagen: An experimental model of arthritis. J. Exp. Med. 146, 857-868.
502. Trentham, D., Dynesius-Trentham, R., Orav, E., Combitchi, D., Lorenzo, G., Sewell, K., Hafler, D., and Weiner, H. (1993). Effects of oral administration of type II collagen on rheumatoid arthritis. Science 261, 1727-1730.
503. van der Heijden, P. J., Bianchi, A. T. J., Dol, M., Pals, J. W., Stok, W., and Bokhout, B. A. (1991). Manipulation of intestinal immune responses against ovalbumin by cholera toxin and its B subunit in mice. Immunology 72, 89-93.
504. van der Heijden, P. J., Stock, W., and Bianchi, A. T. J. (1987). Contribution of immunoglobulin-secreting cells in the murine small intestine to the total 'background' immunoglobulin production. Immunology 62, 551-555.
505. Van de Velde, H., von Hoegen, I., Luo, W., Parnes, J. R., and Thielemans, K. (1991). The B-cell surface protein CD72/Lyb-2 is the ligand for CDS. Nature (London) 351,662-665.
506. van Eden, W., Thole, J. E., van der Zee, R., Noordzij, A., van Embden, J. D., Hensen, E. J., and Cohen, I. R. (1988). Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature (London) 331, 171-173.
507. van Halteren, A. G., van der Cammen, M. J., Cooper, D., Savelkoul, H. F., Kraal, G., and Holt, P. G. (1997). Regulation of antigen-specific IgE, IgGl, and mast cell responses to ingested allergen by mucosal tolerance induction. J. Immunol. 159, 3009-3015.
508. van Hoogstraten, I. M., Andersen, K. E., von Blomberg, B. M., Boden, D., Bruynzeel, D. P., Burrows, D., Camarasa, J. G., Dooms-Goossens, A., Kraal, G., and Lahti, A. (1991). Reduced frequency of nickel allergy upon oral nickel contact at an early age. Clin. Exp. Immunol 85, 441-445.
509. van Hoogstraten, I. M., Boden, D., von Blomberg, M. E., Kraal, G., and Scheper, R. J. (1992). Persistent immune tolerance to nickel and chromium by oral administration prior to cutaneous sensitization. J. Invest. Dermatol. 99, 608-616.
510. van Hoogstraten, I. M., Boos, C., Boden, D., Von Blomberg, M. E., Scheper, R. ]., and Kraal, G. (1993). Oral induction of tolerance to nickel sensitization in mice. J. Invest. Dermatol. 101, 26-31.
511. Van Houten, N., and Blake, S. F. (1996). Direct measurement of anergy of antigen-specific T-cells following oral tolerance induction. J. Immunol. 157, 1337-1341.
512. Vaz, N. M., Maia, L. C. S., Hanson, D. G., and Lynch, J. M. (1977). Inhibition of homocytotropic antibody responses in adult inbred mice by previous feeding of the specific antigen. J. Allergy Clin. Immunol. 60, 110-115.
513. Vaz, N. M., Maia, L. C., Hanson, D. G., and Lynch, J. M. (1981). Cross-suppression of specific immune responses after oral tolerance. Mem. Inst. Oswaldo Cruz 76, 83-91.
514. Vaz, N. M., Rios, M. J., Lopes, L. M., Gontijo, C. M., Castanheira, E. B., Jacquemart, F., and Andrade, L. A. (1987). Genetics of susceptibility to oral tolerance to ovalbumin. Braz. ]. Med. Biol. Res. 20, 785-790.
515. Vaz, N., Faria, A. M. C., Verdolon, B. A., and Can-alho, C. R. (1997). Immaturity, ageing and oral tolerance. Scand. J. Immunol. 46, 225-229.
516. Vidard, L. J., Colarusso, L., and Benacerraf, B. (1994). Specific T-cell tolerance may be preceded by a primary response. Proc. Natl. Acad. Sci. U.S.A. 91, 5627-5631.
517. Viney, J. L., Mowat, A. M., O'Malley, J. M., Williamson, E., and Fanger, N. A. (1998). Expanding dendritic cells in vivo enhances the induction of oral tolerance. J. Immunol. 160, 5815-5825.
518. Vistica, B. P., Chanaud, N. P. R., Felix, N., Caspi, R. R., Rizzo, L. V., Nussenblatt, R. B., and Gery, I. (1996). CDS T-cells are not essential for the induction of "low-dose" oral tolerance. Clin. Immunol. Immunopathol. 78, 196-202.
519. Volkheimer, G. (1975). Hematogenous dissemination of ingested polyvinyl chloride particles. Ann. iV.y. Acad. Sci. 246, 165-171.
520. von Herratli, M. G., Dyrberg, T., and Oldstone, M. B. A. (1996). Oral insulin treatment suppresses virus-induced antigen-specific destruction of beta cells and prevents autoim-mune diabetes in transgenic mice. J. Clin. Invest. 98, 1324-1331.
521. Vrabec, T. R., Gregerson, D. S., Dua, H. S., and Donoso, L. A. (1992). Inhibition of experimental autoimmune uveoretinitis by oral administration of S-antigen and synthetic peptides. Aiitoiminnnity 12, 175-184.
522. Wagner, N., Lohler, J., Tedder, T. F., Rajewsky, K., Muller, W., and Steeber, D. A. (1998). L-Selectin and beta7 integrin synergistically mediate lymphocyte migration to mesenteric lymph nodes. Eur. }. Immunol. 28, 3832-3839.
523. Waldo, F. B., Van Den Wall Bake, A. W. L., Mestecky, J., and Husby, S. (1994). Suppression of the immune response by nasal immunization. Clin. Immunol. Immunopathol. 72,30-34.
524. Walker, W. A. (1986). Antigen handling by the small intestine. Clin. Castroenterol. 15,1-20.
525. Wang, Z. Y., Qiao, J., and Link, H. (1993a). Suppression of experimental autoimmune myasthenia gravis by oral administration of acetylcholine receptor. J. Ncuroimmunol 44, 209-214.
526. Wang, Z. Y., Qiao, J., Melms, A., and Link, H. (1993b). T-cell reactivity to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis. Cell. Immunol 152, 394-404.
527. Wang, Z. Y., Link, H., Ljungdahl, Ä., Höjeberg, B., Link, J., He, B., Qiao, J., Melms, A., and Olsson, T. (1994). Induction of interferon-y, interleukin-4, and transforming growth factor- in rats orally tolerized agaisnt experimental autoimmune myasthenia gravis. Cell. Immunol 157, 353-368.
528. Wang, Z.-Y., He, B., Qiao, J., and Link, H. (1995a). Suppression of experimental autoimmune myasthenia gravis and experimental allergic encephalomyelitis by oral administration of acetylcholine receptor and myelin basic protein: Double tolerance. J. Neuroimmtinol. 63, 79-86.
529. Wang, Z. Y., Huang, J., Olsson, T., He, B., and Link, H. (1995b). B cell responses to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis. J. Neural. Sci. 128, 167-174.
530. Wannemuehler, M. J., Kiyono, H., Babb, J. L., Michalek, S. M., and McGhee, J. R. (1982). Lipopolysaccharide (LPS) regulation of the immune response: LPS converts germfree mice to sensitivity to oral tolerance induction.J. Immunol. 129, 959-965.
531. Weigle, W. O., Thoman, M. L., and Goodman, M. G. (1988). The effect of aging on the induction of tolerance in a subpopulation of B lymphocytes. Cell. Immunol 111,253-257.
532. Weiner, H. L. (1997). Oral tolerance: Immune mechanisms and treatment of autoimmune diseases. Immunol Today 18, 335-343.
533. Weiner, II. L. (1999). Oral tolerance with cop 1 for the treatment of multiple sclerosis. Proc. Null. Acad. Sci. U.S.A. 96, 3333-3335.
534. Weiner, H. L., and Komagata, Y. (1998). Oral tolerance and the treatment of rheumatoid arthritis. Springer Semin. Immunopathol 20, 289-308.
535. Weiner, II. L., and Mayer, L. F. (1996). Oral tolerance: mechanisms and applications. Introduction. Ann. A'.Y. Acad. Sci. 13, xiii-xviii.
536. Weksler, M. E., Russo, C., and Siskind, G. W. (1989). Peripheral T-cells select the B-cell repertoire in old mice. Immunol. Rev. 110, 173-185.
537. Wells, H. G. (1911). Studies on the chemistry of anaphylaxis (III). Experiments with isolated proteins, especially those of the hen's egg.J. Infect. Dis. 8, 147-171.
538. Wells, H. G., and Osbome, T. B. (1911). Biological reactions of the vegetable proteins. I. Anaphylaxis. J. Infect. Dis. 8, 66-123.
539. Whitacre, C. C., Gienapp, I. E., Orosz, G. G., and Bitar, D. (1991). Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence forclonal anergy.J. Immtinol. 147, 2155-2163.
540. Wildner, G., and Thurau, S. R. (1994). Cross-reactivity between an HLA-B27-derived peptide and a retinal autoantigen peptide: A clue to major histocompatibility complex association with autoimmune disease. Ear. J. Immunol. 24, 2579-2585.
541. Wildner, G., and Thurau, S. R. (1995). Orally induced bystander suppression in experimental autoimmune uveoretinitis occurs only in the periphery' and not in the eye. Eur. J. Immunol. 25, 1292-1297.
542. Wildner, G., Hunig, T., and Thurau, S. R. (1996). Orally induced, peptide-specific y/5 TCR cells suppress experimental autoimmune uveitis. Enr. J. Immunol. 26, 2140-2148.
543. Wilson, D. B., Wilson, D. IL, and Schröder, K. (1998). Acquired thymic tolerance and experimental allergic encephalomyelitis in the rat. I. Parameters and analysis of possible mechanisms. Eur. J. Immunol. 28, 2770-2779.
544. Wolvers, D. A., van der Cammen, M. J., and Kraal, G. (1997). Mucosal tolerance is associated with, but independent of, up-regulation Th2 responses. Immunology 92, 328-333.
545. Wolvers, D. A., Bakker, J. M., Bagchus, W. M., and Kraal, G. (1998). The steroid hormone dehydroepiandrosterone (DUEA) breaks intranasally induced tolerance, when administered at time of systemic immunization.J. Immunol. 89, 19-25.
546. Wu, X.-M., Nakashima, M., and Watanabe, T. (1998). Selective suppression of antigenspecific Th2 cells by continuous micro-dose oral tolerance. Eur. J. Immunol. 28,134-142.
547. Xiao, B. G., Bai, X. F., Zhang, G. X., and Link, II. (1998a). Suppression of acute and protracted-relapsing experimental allergic encephalomyelitis by nasal administration of low-dose IL-10 in rats.J. Neuroimmunol. 84, 230-237.
548. Xiao, B. G., Zhang, G. X., Shi, F. D., Ma, C. G., and Link, IL (1998b). Decrease of LFA1 is associated with uprcgulation of TGF-/3 in CD4(+) T-cell clones derived from rats nasally tolerized against experimental autoimmune myasthenia gravis. Clin. Immunol. Immunopathol. 89, 196-204.
549. Xu-Amano, J., Aicher, W. K., Taguchi, T., Kiyono, IL, and McGhee, J. R. (1992). Selective induction of Th2 cells in murine Peyer's patches by oral immunization. Int. Immunol. 4, 433-445.
550. Xu-Amano, J., Kiyono, IL, Jackson, R. J., Staats, H. F., Fujihashi, K., Burrows, P. D., Elson, C. O., Pillai, S., and McGhee, J. R. (1993). Helper T-cell subsets for immunoglobtilin A responses: Oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucossa associated tissues. J. Exp. Med. 178, 1309-1320.
551. Yang, R., Liu, Q., Grosfeld, J., and Pescovitz, M. (1994). Intestinal drainage through liver is prerequisite for oral tolerance induction.J. Fediatr. Surg. 29, 1145-1148.
552. Yoshida, IL, Hachimura, S., Hirahara, K., Hisatsune, T., Nishijima, K., Shiraishi, A., and Kaminogawa, S. (1998). Induction of oral tolerance in splenocyte-reconstituted SCID mice. Clin. Immunol. Immunopathol. 87, 282-291.
553. Yoshino, S. (1995a). Antigen-induced arthritis in rats is suppressed by the inducing antigen administered orally before, but not after immunization. Cell. Immunol. 163, 55-58.
554. Yoshino, S. (1995b). Downregulation of silicone-induced chronic arthritis by gastric administration of type II collagen. Immunophannacology 31, 103-108.
555. Yoshino, S. (1998). Treatment with an anti-IL-4 antibody blocks suppression of collageninduced arthritis in mice by oral administration of type II collagen.J. Immunol. 160,30673071.
556. Yoshino, S., and Yoshino, J. (1998). Effect of a monoclonal antibody against interleukin-4 on suppression of antigen-induced arthritis in mice by oral administration of the inducing antigen. Cell. Immunol. 187, 139-144.
557. Yoshino, S., Quattrocchi, E., and Weiner, II. L. (1995). Oral administration of type II collagen suppresses antigen-induced arthritis in Lewis rats. Arf/irifis Itiieum 38, 1092-1096.
558. Yoshino, S., Ohsawa, M., and Sagai, M. (1998). Diesel exhaust particles block induction of oral tolerance in mice. J. Pliannacol. Exp. Ther. 287, 679-683.
559. Zhang, W., and Kong, Y. C. (1998). Noninvolvement of IL-4 and IL-10 in tolerance induction to experimental autoimmune thyroiditis. Cell. Immunol. 187, 95-102.
560. Zhang, Z., and Michael, J. G. (1990). Orally inducible immune unresponsiveness is abrogated by IFN-ji treatment.J. Immunol. 144, 4163-4165.
561. Zhang, J. Z., Lee, C. S. Y., Lider, O., and Weiner, H. L. (1990). Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen.J. Immunol. 145, 2489-2493.
562. Zhang, J. Z., Davidson, L., Eisenbarth, G., and Weiner, H. L. (1991). Suppression of diabetes in NOD mice by oral administration of porcine insulin. Proc. Natl. Acad. Sci. U.S.A. 88, 10252-10256.
563. Zhang, J., Markovic, S., Raus, J., Lacet, B., Weiner, H. L., and Hafler, D. A. (1993). Increased frequency of IL-2 responsive T-cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis.J. Exp. Med. 179, 973-984.
564. Zhang, G.-X., Shi, F.-D., Zhu, J., Xiao, B.-G., Levi, M., Wahren, B., Yu,-L.-Y. and Link, H. (1998). Synthetic peptides fail to induce nasal tolerance to experimental autoimmune myasthenia gravis. J. Netiroimmunol. 85, 96-101.
565. Zivny, J. H., Russell, M. W., Vu, H. L., Moldoveanu, J., Mestecky, J., and Elson, C. O. (1996). Multiple mechanisms of oral tolerance to food antigens in humans. FASEB J. 10, A1116.
566. Zou, L.-P., Zhu, J., Deng, G.-M., Levi, M., Wahren, B., Diab, A., Hillert, J., and Link, H. (1998). Treatment with P2 protein peptide 57-81 by nasal route is effective in Lewis rat experimental autoimmune neuritis.J. Neuroimmunol. 85, 137-145.